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ABSTRACT
Aflatoxin is a liver carcinogen, mycotoxin, and a secondary metabolite that is
produced by some plant pathogens within the genus Aspergillus when they infect crops
such as corn, peanuts, and cotton. Given the significant adverse health and economic
impacts of aflatoxin and a predicted rise of crop contamination with mycotoxins caused
by a changing climate, there is a pressing need for exploring new aflatoxin mitigation
methods. Previous studies in our laboratory have shown that metabolites from Vibrio
gazogenes, an estuarine non-pathogenic bacterium, can inhibit aflatoxin synthesis.
However, a direct interaction study between V. gazogenes and aflatoxin producing strains
has not been conducted thus far. Here we show that administration of V. gazogenes in the
growth medium of Aspergillus flavus, an aflatoxin producing pathogen in corn, results in
an almost complete inhibition (>99%) of aflatoxin biosynthesis at the level of gene
expression. Light, electron and confocal microscopy suggested that V. gazogenes
dependent aflatoxin inhibition was associated with internalization of bacterial cell
materials but not intact bacteria, in endosome-like compartments. Administration of equal
concentrations of heat-inactivated non-viable V. gazogenes cells to the growth medium
resulted in a similar reduction in aflatoxin production, supporting that bacterial viability
was not necessary for this inhibitory effect. We show that sclerotial development which
depends on hyphal fusion decreased by more than 2-fold as well. Mycelia upon V.
gazogenes administration showed early conidiation; however, conidia harvested from the
treated colonies produced ~2-fold less aflatoxin than the earlier generation. We also show
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that, V. gazogenes uptake results in an almost complete (>98%) block of hyphal fusion
and an ~3-fold decrease of polar growth, processes that depend on endosomal functions,
and transport. We have also found that A. flavus cannot uptake the same amount of V.
gazogenes in the presence of endocytosis inhibitors which also affect the aflatoxin
inhibition. In another study, we observed that, presence of A. flavus activates V.
gazogenes lysing enzymes. Treating A. flavus with non-viable other gram-positive or
gram-negative or prodigiosin producing bacterium did not have the same aflatoxin
inhibitory effect. This indicates that the anti-aflatoxigenic activity is specific to V.
gazogenes and prodigiosin is not the only aflatoxin inhibitor. Our study showed that,
Intact V. gazogenes cells most effectively and efficiently decrease aflatoxin production
(>99%) rather than different fractionated parts of V. gazogenes cells. Collectively, our
study introduces a novel cellular perturbation tool through V. gazogenes that can allow us
to identify the interconnected molecular and cellular mechanisms that co-regulate
secondary metabolism and hyphal development in filamentous fungi, hence providing a
novel starting point for the discovery of a safe pharmaceutical and green fungicidal
product that can efficiently prevent aflatoxins which have profound impacts on
agriculture, environmental sustainability, and human health. The study ultimately unlocks
an opportunity for furthering fundamental science and developing practically applicable
strategies for intervening in Aspergillus toxin accumulation in the environment.
.
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CHAPTER 1
INTRODUCTION
1.1 AFLATOXINS
Aflatoxins (AFs) are remarkably potent, most acutely toxic, an ever-increasing
number of chemical carcinogenic mycotoxin. They were discovered because of their
toxicity to turkeys, chicks, and ducklings in British hatcheries in 1960 (Bennett and
Christensen, 1983). The poultry deaths were traced to a mold-contaminated Brazilian
peanut meal and received publicity as a mysterious “Turkey-X disease.” The mold from
the toxic peanut meal was identified as Aspergillus; extraction of a purified toxic principle
from cultures of Aspergillus flavus was reported by two groups in 1962 (Nesbitt et al.,
1962; Van Der Zijden et al., 1962). A study on the nature of the toxin suggested its origin
from the fungus A. flavus. Thus, the toxin was named “aflatoxin” by its origin from A.
flavus (Brase S, 2013). This was the event that stimulated scientific interest and gave rise
to modern mycotoxicology. Research on aflatoxins led to a “golden age” of mycotoxin
research during which several new mycotoxins were discovered (Negash, 2018).
Aflatoxins (AFs) are a group of homologous estrogenic mycotoxin and pervasive,
are low molecular weight molecules of structurally related toxic secondary metabolites
mainly produced by Aspergillus genus including A. flavus and A. parasiticus and A.
nomius, during favorable growth conditions of oxygen, moisture (3-18%), warm
temperatures (24-35oC) and substrate (sugar) (Gummadidala, 2018; Iqbal et al., 2014; Ji
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and Xie, 2020; Zhuang et al., 2016). The aflatoxins, B1, B2, G1 and G2 (AFB1, AFB2,
AFG1 and AFG2) are the major four toxins among at least 20 structurally related toxins
which are named based on their respective blue and green fluorescence under long-wave
ultraviolet (UV) light and their relative mobility by thin-layer chromatography on silica gel
(Bennett and Christensen, 1983; Pitt, 2000; Yu, 2012) and aflatoxin M1 (AFM1) and
aflatoxin M2 (AFM2) are the hydroxylated metabolites of AFB1 and AFB2 produced
through different metabolic processes and expressed in animals and animal products
(Kumar et al., 2016). Aflatoxin is biosynthesized by many Aspergillus species such as A.
flavus, A. parasiticus, A. nominus, A. pseutotamarii, A. bombycis, A. toxicarius, A.
parvisclerotigenus, A. minisclerotigenes, A. arachidicola, and A. pseudocaelatus. But
primarily aflatoxins are produced in copious amounts by A. flavus and A. parasiticus,
which can cohabit and flourish on practically any crop or food including but not limiting
to maize, oilseeds, spices, groundnuts, tree nuts, milk, and dried fruit (Bennett and Klich,
2003a; Strosnider et al., 2006). Aflatoxin B1 is predominant, the most toxic and most
potent hepatocarcinogenic natural compound ever characterized, as well as heat resistant
over a wide range of temperatures, including those reached during commercial processing
conditions (Sirot et al., 2012). Aflatoxins (AFs) are polyketide-derived secondary
metabolites and their structures are composed of bis-furan-containing dihydrofuran furan
and tetrahydrofuran moieties (5 rings) fused with a substituted coumarin (an aromatic ring),
a lactone ring and either a pentanone or a lactone ring (Brase S, 2013; Yu et al., 2005)
(Figure 1.1).
Aflatoxin is the only mycotoxin known to contaminate crops both pre- and postharvest (potentially along the entire value chain), making it difficult to target prevention
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and control interventions (Ayalew et al., 2016; Visser et al., 2020). Aspergillus can
synthesize aflatoxin during postharvest handling of storage, transportation, and food
processing (Wu and Khlangwiset, 2010). The Food and Agriculture Organization estimates
that 25% of the world’s crops are contaminated with aflatoxins, resulting in annual losses
of around 1 billion metric tons of foods and food products (Alexandratos and Bruinsma,
2012). Recent reports from our group and others suggest that the risk of consuming foods
with various mycotoxins is increasing steadily (Chen et al., 2018b; Gummadidala et al.,
2019b; Herrera et al., 2019; Ortiz et al., 2018). Over 5 billion people in developing
countries are at risk of chronic dietary exposure to aflatoxins, the hepatocarcinogenic
mycotoxins. Losses due to aflatoxin alone range from $52.1 to $1.68 billion annually, and
it is predicted that the impending climate change will increase mycotoxin contamination in
crops, foods, and feed (Battilani et al., 2016; Mitchell et al., 2016b; Wu and Mitchell,
2016). Recent studies show that > 50% of ~ 40 million units of infant foods or breakfast
cereals sold per week in the USA contain at least one (mycotoxin) (Zhang et al., 2018a).
Despite years of efforts, there is still no precise method to prevent diseases and economic
losses resulting from fungal infections and dietary exposures to aflatoxin and other
mycotoxins (Herrman et al., 2020). In the USA alone, the number of samples tested
positive for aflatoxin increased by 6% from 2012 to 2013. FDA limits for aflatoxin human
consumption is 20 ppb, animal feeds is 300 ppb and for aflatoxin M1 in milk is 0.5 ppb
(FDA, 2011). National estimates of dietary exposure to aflatoxins indicate differences
between developed and developing countries. In developed countries, mean aflatoxin
dietary exposures are generally less than 1 ng/kg body weight (BW) per day (a nanogram
is one billionth [1×10-9] of a gram), whereas estimates for some sub-Saharan African
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countries exceed 100 ng/kg BW per day, although these latter estimates are often based on
very few data (World Health and Joint, 2017).
Aflatoxins have both hepatotoxic and carcinogenic actions, depending on the level
and duration of exposure. It contaminates crops, produce, food, nuts, cereal, milk, juices,
homes, wood, etc., and can be ingested into intestines and enter systemic circulation
(Figure 1.2) and cause acute illness and deaths (Alshannaq et al., 2018). The ingestion of
aflatoxins in contaminated food or feed causes a disease called aflatoxicosis. Acute
aflatoxicosis is produced when moderate to high levels of aflatoxins are consumed.
Symptoms include acute liver damage, acute necrosis, cirrhosis, or in severe cases, acute
liver failure, and death (Fung and Clark, 2004). Aflatoxins in the liver irreversibly bind to
protein and DNA to form adducts such as aflatoxin B1-lysine in albumin (Skipper and
Tannenbaum, 1990). Disruption of the proteins and DNA bases in hepatocytes causes liver
toxicity (Azziz-Baumgartner et al., 2005). In humans, patients experience high fever, rapid
progressive jaundice, edema of the limbs, pain, vomiting, alteration in digestion, absorption
and/or metabolism of nutrients and swollen livers(Yu et al., 2005). Aflatoxin B1 has been
categorized as class 1A human carcinogen by the International Agency of Research on
Cancer (IARC) because it causes hepatocellular carcinoma. It is projected that 25,200155,000 cases of liver cancer worldwide are attributed to aflatoxin exposure (Wu et al.,
2011).
1.2 BIOSYNTHESIS OF AFLATOXINS
Aflatoxins, typical of other secondary metabolites, are produced during idiophase,
after primary growth has slowed. Induction of aflatoxin biosynthesis appears to involve the
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interplay of transcriptional regulatory elements and physiological factors that affect fungal
metabolism (Payne and Brown, 1998). The hallmark discovery of a color mutant that
accumulates the brick-red pigment, norsolorinic acid (NOR), in A. parasiticus marked a
milestone in the understanding of the chemistry of aflatoxin biosynthesis (Bennett, 1979;
Bennett et al., 1997; Bennett and Klich, 2003b). This discovery led to the identification of
other key aflatoxin intermediates and established the early step metabolites in the aflatoxin
pathway. It provided the opportunity to isolate the first aflatoxin pathway gene that
encoding a reductase for the conversion from NOR to eventually aflatoxins (Ehrlich et al.,
2008; Hsieh et al., 1973; Hsieh and Mateles, 1970; Yu, 2012).
The biosynthetic pathway of aflatoxins consists of 21 enzymatic steps for
conversion from acetyl-CoA, and at least 30 genes encoding the enzymes and regulatory
pathways have been cloned and characterized (Yu et al., 2004b). Genes (aflR and aflJ)
coding for proteins shown to be involved in transcriptional activation of most of the
structural genes are also part of the cluster (Bhatnagar et al., 2003). The aflatoxin gene
cluster has been widely studied in A. flavus and A. parasiticus. The homology of the
clustered genes between the two fungal species is 90%–99% (Fung and Clark, 2004). One
of the main differences between the two species is their ability to produce B and G type
aflatoxins (Caceres et al., 2020). In A. flavus and A. parasiticus the aflatoxin pathway
genes are clustered within a 75-kb region of the fungal genome on chromosome III roughly
80 kb away from telomere (Chang et al., 2005; Trail et al., 1995; Wilson, 1989; Yu et al.,
2004a) (Figure 1.3) and is regulated by the regulatory gene, aflR (Price et al., 2006; Yabe
and Nakajima, 2004)
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Aflatoxins are polyketide-derived secondary metabolites produced via the
following conversion path (Bhatnagar et al., 2003; Yabe et al., 1988; Yu et al., 2004b):
acetate → polyketide → anthraquinones → xanthones → aflatoxins.
Initially, acetate and malonyl-CoA are converted to a hexanoyl unit by a specialized fatty
acid synthase. aflA (fas-2), aflB (fas-1), and aflC (pksA) are involved in the conversion of
acetate to NOR. The polyketide then undergoes multiple enzymatic conversions in the
pathway. In the middle of the of the pathway, intermediate versicolorin B synthase
catalyzes an important step that is responsible for the bisfuran ring required to bind
aflatoxin to DNA (Payne and Brown, 1998). Versicolorin B is situated at the branching
step of the pathway where the conversion of Versicolorin B to Sterigmatocystin (ST) leads
to the production of aflatoxin B1 and the conversion of versicolorin B to dihydrode methyl
sterigmatocystin leads to the production of aflatoxin B2 (Mitra et al., 2017).
1.3 ASPERGILLUS FLAVUS
The genus Aspergillus was first described by the Florentine priest and mycologist
P. A. Micheli in 1729 and named based on the structural similarity of its conidiophore
structure to the aspergillum, a liturgical implement used to sprinkle holy water (Bennett
and Klich, 1992). This common genus has been classified based on morphology many
times (Samson, 1992) and currently contains over 200 species. It is a common saprophytic
aerobic fungus. It belongs to the family of Aspergillaceae in the phylum of Ascomycota
and is mainly distributed in the warm temperate zone (Klich, 2007). Aspergillus flavus was
described by Link in 1809 and has been known as an asexual species that only produces
asexual spores, conidia, and the overwintering asexual fruiting bodies, sclerotia. Recently,
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the sexual stage of A. flavus has been reported and classified as Petromyces flavus (Amaike
and Keller, 2011; Horn et al., 2009). Most A.flavus strains are susceptible to antifungal
therapy but the minimum inhibitory concentrations are at least two-fold higher than for
other Aspergillus species (Frawley et al., 2020; Krishnan et al., 2009). Furthermore, recent
discoveries revealed the presence of active multidrug-resistant genes in A.flavus strains
increasing their potential for drug resistance and pathogenicity (Tobin et al., 1997).
Aflatoxin B1 synthesized by A.flavus is extremely stable and cannot be detoxified by
cooking or autoclaving and thus pollutes many food groups being ingested by humans and
animals (Gummadidala, 2018).
Aspergillus flavus have worldwide distribution and can infest a wide range of
agricultural products. It is not only a common pathogen of plants but also a human
pathogen, and long-term exposure to A. flavus or more than 20 other species in humans and
animals can induce asthma, exogenous alveoli, and allergic bronchial aspergillosis
(Hedayati et al., 2007b). It has pathogenic ability causing aspergillosis in immunocompromised humans effecting the skin, oral mucosa, and subcutaneous tissues. According
to the centers for disease control and prevention (CDC) approximately 4.8 million cases of
aspergillosis were diagnosed worldwide and A.flavus is the second most leading cause.
A.flavus also infects corn, peanuts, and cotton by releasing aflatoxins. Aflatoxin B1, an
A.flavus secondary metabolite, has been categorized as class 1A human carcinogen by the
International Agency of Research on Cancer (IARC). During the growth, transportation,
and storage of crops, A. flavus can induce various crop diseases like ear rot in corn, algarot
in peanuts, and boll rot in cotton (Yu et al., 2005). Food safety issues caused by A. flavus
are due to its representative secondary metabolites: aflatoxins (AFs), cyclopiazonic acid
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(CPA), and aspertoxin, aflatrem and aspergillic acid (Li et al., 2019; Soni et al., 2020). The
growth of A. flavus and synthesis of aflatoxins depends on substrate, pH, temperature,
moisture, aeration, and competing micro-flora. It produces airborne conidia, which easily
disperse by air movement or by insects. A. flavus is considered as an opportunistic pathogen
that takes advantage of an opportunity not normally available, such as a host with a
weakened immune system, and altered micro-biota for colonization (Tahira Aziz Mughal
et al., 2020). It is not only a common pathogen of plants but also a human pathogen, and
long-term exposure to A. flavus or more than 20 other species in humans and animals can
induce asthma, exogenous alveoli, and allergic bronchial aspergillosis (Hedayati et al.,
2007b). A. flavus colonization does not necessarily reduce yield but causes economic losses
by contaminating seed with aflatoxin.
1.4 INHIBITORS TO STOP AFLATOXIN BIOSYNTHESIS
In recent decades, several feasible and cost-effective strategies have entered the
market aiming to mitigate the effects of feed mycotoxin contamination in food and animal
feeds. Technologies to reduce the incidence of mold and mycotoxin contaminations of
silages can be employed in one of the three main phases (preharvest, harvest, ensiling) of
silage production. Aflatoxin mitigation has been well documented in the recently released
Synthesis of the Research on Aflatoxin in Health, Agriculture, and Trade (USAID, 2012).
The pre-harvest solutions currently available are based on good Agricultural Practices,
which typically include use of fungal resistant crops, good tillage and weeding practices,
appropriate use of fertilizers, irrigation, and crop rotation (Ehrlich et al., 2008; Kimanya,
2008; Leslie et al., 2008; Waliyar et al., 2013) while post-harvest screening to remove
contaminated seed appears to be a promising means to reduce or to eliminate aflatoxin
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(Hell et al., 2008). There are several processing methods like sorting, washing, dehulling
grain mechanically, roasting, cooking, wet and dry milling, canning, baking, frying, and
extrusion cooking can reduce aflatoxin contamination up to 80% in crops and grains after
harvesting (Negash, 2018). According to (Bovo et al., 2013) toxin absorbents, chemical,
and biological methods are used directly for reducing aflatoxin in milk.
Various synthetic compounds are used extensively to control the fungal infestation,
but there are concerns about the environmental health hazards of using these chemicals.
Use of ethylene and carbon dioxide inhibit aflatoxin synthesis in the laboratory-grown A.
parasiticus on peanuts (Gunterus et al., 2007) while some phenolic compounds such as
acetosyringone, and syringaldehyde can inhibit aflatoxin biosynthesis in A. flavus
efficiently (Molyneux et al., 2007) but they also contaminate soil and water. There are
some studies on using plant extracts such as asafoetida, turmeric, and Azadirachta indica
leaf extract to prevent aflatoxin production in groundnuts (Ghewande and Nagaraj, 1987).
Physical and chemical methods lead to unwanted side effects, and adsorptionassociated technologies still have limitations, such as aflatoxin residues in foods, feeds,
and hosts. One of the best ways to remove aflatoxin is detoxifying action for successful
decontamination. Accordingly, to compensate for these drawbacks, microbe-mediated
biodegradation methods have been suggested for effective control of aflatoxin
contamination at a higher rate. Indeed, many studies have reported aflatoxin-degrading
fungal and bacterial strains isolated from soil, feces, and crops. However, the use of living
microorganisms as a food additive may raise safety issues and consumers may be reluctant
to eat microbe-supplemented foods. The use of aflatoxin-degrading enzymes, produced by
fungi and bacteria, may be able to overcome those drawbacks. To meet the emerging need,
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using microorganisms and their metabolites as biocontrol agents against aflatoxin and other
mycotoxins become a fruitful solution. Some examples include studies with Bacillus spp.
such as Bacillus subtilis, Lactobacillus spp., Pseudomonas spp., Ralstonia spp., and
Burkholderia spp. (Chalivendra et al., 2018; Guo et al., 2019; Palumbo et al., 2006a;
Strosnider et al., 2006), Lactobacillus spp. (Ahlberg et al., 2017; Gonda et al., 2019;
Guimarães et al., 2018), Pseudomonas spp. and Ralstonia spp. (Spraker et al., 2014;
Spraker et al., 2016), Trichoderma spp. (Waliyar et al., 2015), Streptomyces spp. (Sakuda
et al., 2016; Yoshinari et al., 2010), Aspergillus oryzae (Alshannaq et al., 2018). Recently
we discovered that a non-pathogenic estuarine bacteria Vibrio gazogenes inhibit aflatoxin
biosynthesis by A. flavus without inhibiting the fungal growth (Gummadidala, 2018).
1.5 VIBRIO GAZOGENES
Vibrio gazogenes(Allen et al., 1983; Giovannoni and Margulis, 1981; Harwood,
1978; Ratcliffe et al., 1982) is a red-pigmented species that was described in 1978 by
Harwood (Harwood, 1978). The organism was described as oxidase-positive and was
named Beneckea gazogenes, but it was later classified in the genus Vibrio and the oxidase
reaction (negative) was corrected. The original description was based on a single culture
isolated from a saltwater marsh located near Woods Hole, Mass. (Giovannoni and
Margulis, 1981). Vibrio gazogenes is a rod shaped, gram-negative facultative anaerobe
marine gram-negative bacterium notoriously known for its synthesis of antifungal
pigments. V. gazogenes is a non-pathogenic bacteria and fluorescent carboxylate
nanoparticles have a positive effect on the growth of this bacterium (Jones, 2016).
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Studies have shown that when V.gazogenes comes in contact with aflatoxin, the
toxin induces V.gazogenes to synthesize antifungal and anti-aflatoxin compounds
(Gummadidala et al., 2016). The utility of prodigiosin that are synthesized by V. gazogenes
ATCC 43942, coupled with its ability to produce unique antibiotics and mycotoxin
inhibitors under custom-designed environmental settings makes this strain “chemically
gifted.” In this context, its finished genomic sequence provides a necessary point of
comparison with other V. gazogenes strains and bacterial species within the Vibrio genus
for the elucidation of the molecular factors that govern its unique metabolic profile
(Gummadidala et al., 2017). Understanding the mechanism by which V. gazogenes secrets
aflatoxin inhibitory metabolic components which cause a decrease of aflatoxin and inhibits
pathogenicity of A.flavus will help us further understand how to develop, design and target
A.flavus pathogen and decrease mortality rates of fungal infected patients and plants.
1.6 BACTERIA-FUNGAL INTERACTION
Bacterial-fungal interactions are widespread in nature and there is a growing
number of studies reporting distinct fungus-associated bacteria. However, little is known
so far about how shifts in the fungus-associated bacteriome will affect the fungal host’s
lifestyle (Schulz-Bohm et al., 2017). Microbes ubiquitously occur in the environment and
colonize almost every ecological niche. Because of this high abundance, different species
coinhabit certain habitats and as a consequence interact with each other. Such encounters
probably represent the driving force to produce secondary metabolites that regulate the
coexistence and survival of different species (Scherlach et al., 2013). Hence, it is thought
that microbial SMs play an important role in intraspecific and interspecific interactions,
including cross-kingdom communication (Davies, 2013; Han et al., 2017; Schulz-Bohm et
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al., 2017). SMs have profound impacts on the ability of these microbes to colonize and
survive in complex biotic environments and that microbes respond to specific SM signals
as part of a complex network of interactions (Spraker et al., 2018b). Moreover, fungalbacterial associations are widely used for the preservation of the environment (e.g.,
mycorrhizae in reforestation), agriculture (e.g., food processing), and biotechnology (e.g.,
pharmaceutical research) (Scherlach et al., 2013). Beyond the most commonly observed
microbial cell-cell interactions, there is a growing number of known endosymbioses where
bacteria dwell within fungal hyphae (Bonfante and Anca, 2009; Frey-Klett et al., 2011;
Kobayashi and Crouch, 2009; Lackner et al., 2009). Symbioses with endofungal bacteria
are often overlooked, yet they may have a profound effect on the host's lifestyle. Bacterial
endosymbionts of arbuscular mycorrhizal fungi, for example, might be implicated in the
vitamin B12 provision for the fungus (Ghignone et al., 2012).
Epigenetics has been steadily gaining momentum in the last few decades in the
world of transcriptional regulation. There is now growing evidence that microbial
communication regulates epigenetic modifiers that in turn control mycotoxin biosynthesis.
The SAGA complex, conserved across eukaryotes, induces transcription of genes by
mediating histone acetylation of the corresponding promoters. Researchers showed that,
Pseudomonas piscium, from the wheat head microbiome, secretes an antifungal agent,
phenazine, against F. graminearum. Phenazine, upon entering the fungal cell, inhibits the
histone acetyltransferase module of the SAGA complex which subsequently leads to an
inhibition of fungal growth and pathogenicity in addition to a complete suppression of
DON biosynthesis (Chen et al., 2018b). Another similar instance has been reported in
Aspergillus nidulans—Streptomyces rapamycinicus association where the bacterium
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induces histone modification mediated by the SAGA complex which results in the
production of orsellinic acid and its derivatives by the fungus (Nützmann et al., 2011). It
is indeed fascinating that microbes have evolved such well-tuned, intricately regulated
mechanisms of interaction. Bacteria have been shown to contribute to the reduction of
Fusarium mycotoxin accumulation in grains. Preventative application of Pseudomonas
fluorescens strain before inoculation with F. culmorum resulted in a significant reduction
in Fusarium head blight as well as DON levels in infected wheat grains(Khan and Doohan,
2009). Endophytes belonging to Paenibacillus polymyxa, isolated from wild teosinte, have
been shown to produce fusaridins which contribute to the antifungal activity against F.
graminearum. The co-existence of these bacteria with F. graminearum in grains during
storage at room temperature resulted in a significant decrease in DON accumulation
(Mousa et al., 2015). A recent review summarizes the different bacteria and fungi that can
degrade mycotoxins including zearalenone and DON (Vanhoutte et al., 2016; Venkatesh
and Keller, 2019). Another study showed that rice seedling blight fungus Rhizopus
microsporus and its endosymbiont Burkholderia rhizoxinica form an unusual, highly
specific alliance to produce the highly potent antimitotic phytotoxin rhizoxin (Moebius et
al., 2014).
Yeast and several lactic acid bacteria can bind aflatoxins, decreasing aflatoxin
bioavailability in feed or food. Because lactic acid bacteria prevent the growth of
pathogenic bacteria by producing pathogen-inhibitory substances, and most are used as
probiotics and generally regarded as safe, they are considered a desirable method for
aflatoxin removal(Hernandez-Mendoza et al., 2009). Among lactic acid bacteria, physical
adsorption by Lactobacillus rhamnosus GG has been extensively studied (Kim et al.,
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2017). Enterococcus faecium strains isolated from the feces of healthy dogs have been
shown to reduce the levels of aflatoxin B1 which were suggested as promising pet feed
additives for aflatoxin decontamination.

Some other examples are: Saccharomyces

cerevisiae adsorb aflatoxin (Dogi et al., 2011; Luo et al., 2020; Pizzolitto et al., 2013),
aflatoxin-binding bacterial strain, Brevibacillus lacterosporus also use for controlling
aflatoxin contamination in feeds (Aftabi et al., 2015). Aflatoxin B1 biosynthesis and
mycelial growth were inhibited and the inhibitory activity was occurred due to extracellular
metabolites produced in cell-free supernatant fluids of the cultured broth of Lactobacillus
casei (Chang and Kim, 2007).
It is expected that descriptions of bacteria mediated fungal growth and their
aflatoxin inhibition will continue to accumulate as a result of growing interest in the field,
as well as the greater appreciation by the scientific community of fungi as simple model
systems. Also, the recognition that sophisticated cellular machinery previously associated
with bacterial producing metabolic components in contact with fungal toxin has initiated
an exciting area of research involving effector molecules and their fungal targets, which in
turn could lead to new strategies for controlling fungal pathogens of plants. Those potential
research could be extended to direct use of bacteria in the market or in the field to prolong
the shelf life of commodities as a biological control agent. As an essential parameter, the
safety of the antagonistic bacterium and its metabolites using a food model system
currently needs to be evaluated. Bacteria-fungal interactions result in unique contributions
to biogeochemical cycles and biotechnological processes. Thus, the interactions between
bacteria and fungi are of central importance to numerous biological questions in
agriculture, forestry, environmental science, food production, and medicine.

14

1.7 PREVIOUS WORK
Previous researchers from our lab, used Vibrio gazogenes, a non-pathogenic gramnegative marine bacterium, which was proven to synthesize antifungal and anti-aflatoxin
metabolites. In their research study they used Aspergillus parasiticus and Aspergillus
flavus – two saprophytic pathogenic fungi as aflatoxin-producing models. Their research
study showed that, by treating V. gazogenes with aflatoxin, produced aflatoxin responsive
metabolites (ARMs) that could significantly decrease aflatoxin synthesis by inhibiting the
aflatoxin genes (aflR, nor-1, ver-1) and global secondary metabolism genes (LaeA, VeA).
But the decrease in aflatoxin was only 40%. They treated the fungal cultures with the cells
of V. gazogenes and the aflatoxin ELISAs revealed the significant decrease (>99%) in
aflatoxin biosynthesis by the fungi. The aflatoxin inhibitory effect was very specific to V.
gazogenes and not to other gram-positive or gram-negative bacteria. Fungal conidial
growth and aflatoxin significantly decrease by 50% and 98% respectively after infecting
corn kernels with A. flavus in the presence of the bacterium. Drosophila flies survival
increased after treating with V. gazogenes before A. flavus infection. The research study
also showed the uptake of the bacterium by the fungus into vesicles in scanning electron
and transmission electron microscopies. RT-PCR assays revealed that live V. gazogenes
cells significantly up-regulate aflatoxin genes (aflR, nor-1, ver-1) and global secondary
metabolite genes (laeA, veA). The pathway through which V. gazogenes inhibits aflatoxin
is complicating. A previous study from our lab had developed a novel tool (V. gazogenes)
to inhibit the aflatoxin biosynthesis, which is acting at the cellular level rather than at the
gene level.
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1.8 CURRENT STUDIES FOCUSED ON THIS
To understand the toxigenicity of A. flavus in response to V. gazogenes cells, we
focused on Vibrio-Aspergillus interaction experiments. Our first target to know, where V.
gazogenes cells gone in the media when they meet A. flavus. We also want to understand
if V. gazogenes internalized within hyphae during the inhibition of aflatoxin production.
So, we determined whether bacterial cells were taken up by the growing mycelia. Given
that we did not find any evidence of intact bacterium on the surface and inside of the fungal
cells, we hypothesized that the viability of V. gazogenes was not essential for V. gazogenes
-dependent aflatoxin reduction. To test this hypothesis, we sought to determine if heattreated non-viable V. gazogenes could result in a similar reduction of aflatoxin production
in A. flavus as the viable V. gazogenes. As a first step to determine the mechanisms
underlying Vibrio gazogenes -dependent aflatoxin reduction, we determined whether the
V. gazogenes treatment was able to restrict aflatoxin biosynthesis at the level of
transcription activation of aflatoxin genes.
Due to our Vibro-Aspergillus interaction experiments, we found almost complete
inhibition of aflatoxin when the bacteria internalized through endocytosis (vesicular
uptake) by the fungus. So, we did some more relative experiments to observed sclerotia
formation, hyphal polarization, and hyphal fusion etc. in A. flavus. Conidia and sclerotia
contain aflatoxin and studies have positively correlated sclerotial development with
aflatoxin production. we proceeded to test whether, sclerotia development is restricted, in
a V. gazogenes -dependent manner. In consistence with our theory that V. gazogenes
components upon internalization within hyphae, intervene in normal endosomal functions,
we have also observed that hyphal elongation, a process that also relies on endocytosis and
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normally functioning endosomes, was significantly inhibited. Since we observed V.
gazogenes components in organelles that appeared to be endosomes, we proceeded to test
whether hyphal fusion, a fundamental biological process of filamentous fungi, and which
is coordinated by the endocytic machinery and endosomal transport, is impeded in a V.
gazogenes -dependent manner.
To understand the effect of the uptake of V. gazogenes cells through endocytosis
we treated A. flavus with endocytosis inhibitors (filipin and natamycin). Next, we
investigated if V. gazogenes cells lysed in the presence of A. flavus because we did not
observe any evidence of intact bacterium within the hyphal cells with transmission electron
microscopy in our previous studies. To understand if the prodigiosin produce by V.
gazogenes is the only aflatoxin inhibitor, we treated A. flavus with a gram-negative
bacterium, Serratia sp., which also secrete a host of virulence factors including prodigiosin.
Since we observed prodigiosin is not the only functional component that is specific to V.
gazogenes, we proceeded to test whether intact and fractionated V. gazogenes cells are
impeded aflatoxin reduction in the same manner.
Our studies raise the idea of potentially using a food-grade V.gazogenes strain as a
potential biocontrol agent to reduce A. favus aflatoxin contamination. Our research results,
along with further studies, will eventually provide a novel product(s) that can be used as a
natural anti-fungal and anti-aflatoxin agent. In particular, the increasing availability of
sequenced genomes and modern molecular methods to facilitate high-throughput studies
will undoubtedly improve our understanding of host/pathogen interactions in the context
of both agricultural and human health sciences.
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Figure 1.1: Chemical structures of the major types of aflatoxins (Peles et al., 2019)

18

Figure 1.2: Schematic presentation summarizing the major AFB1 and AFM1 exposure
routes and adverse health effect
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Figure 1.3: The gene cluster responsible for aflatoxin biosynthesis in A. flavus (A)
Clustered genes (arrows indicate the direction of gene transcription) and (B) the aflatoxin
biosynthetic pathway. The ST biosynthetic pathway genes in A. flavus are indicated at
the right of panel B. Arrows in panel B connect the genes to the proteins they encode.
Abbreviations: NOR, norsolorinic acid; AVN, averantin; HAVN, 5¢-hydroxy-averantin;
OAVN, oxoaverantin; AVNN, averufanin; AVF, averufin; VHA, versiconal hemiacetal
acetate; VAL, versiconal; VERB, versicolorin B; VERA, versicolorin A; DMST, demethyl sterigmatocystin; DHDMST, dihydrode methyl sterigmatocystin; ST,
sterigmatocystin; DHST, dihydro sterigmatocystin; OMST, O-methyl sterigmatocystin;
DHOMST, dihydro-O-methyl sterigmatocystin (Yu et al., 2004b)
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CHAPTER 2
Vibrio gazogenes DEPENDENT INHIBITION ON AFLATOXIN
BIOSYNTHESIS IN Aspergillus flavus
2.1 INTRODUCTION
With changes in global climate, mycotoxin (aflatoxin) contamination of
agricultural commodities from Aspergilli and other fungal pathogens continues to rise and
poses a growing threat to human health (Bayman and Baker, 2006; Boonen et al., 2012;
Buller, 1931; Carlile et al., 1994; CAST, 2003b; Chang and Kim, 2007; Cullen et al., 1994;
Eaton and Groopman, 2013; Gow and Gadd, 2007; Ingold, 2012; Moss, 1986; Payne et al.,
1993; Peñalva and Arst, 2002; Trail et al., 1995; Yin et al., 2008). While compounds that
inhibit mycotoxin-synthesis (especially aflatoxin-synthesis) exist, infants and toddlers are
still at risk of mycotoxin exposures (Gummadidala et al., 2019b; Zhang et al., 2018b),
which can impair growth and development in children, weaken their immune system and
make them vulnerable to infections and other health disorders including cancer.
Aflatoxin B1, a mycotoxin produced primarily by Aspergillus flavus is the most
potent naturally occurring carcinogen (Coppock et al., 2018) and contamination levels are
predicted to increase due to impending climate change (Battilani et al., 2016). Estimated
U.S. losses range from $52.1 million to $1.68 billion annually for aflatoxin alone (Mitchell
et al., 2016a). With liver carcinomas already being the third leading cause of cancer-related
mortality worldwide, the global increase in the prevalence of hepatitis B virus (HBV) and
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immunocompromised population has increased the risk of aflatoxin-induced liver cancer
(Liu and Wu, 2010). NIH statistics indicate that 16,600 new cases of aflatoxin-induced
liver cancer annually in the US (Kensler et al., 2011). The elimination of aflatoxin
accumulation in food and feed, therefore, is of primary importance for reducing its global
burden on public health and economy.
Despite years of efforts, there is still no precise method to reduce dietary exposures
to aflatoxin and other mycotoxins. To address this need, the use of microflora and their
metabolites as biocontrol agents against aflatoxin and other mycotoxins are becoming
increasingly popular (Kagot et al., 2019; Khalid et al., 2018; Palumbo et al., 2006b; Spraker
et al., 2018a). Bacteria and fungi can form a range of physical associations that depend on
various modes of molecular communication for their development and functioning. These
bacterial-fungal interactions often result in changes to the pathogenicity or the nutritional
influence of one or both partners toward plants and animals (including humans). Here we
present a structured research study of bacterial-fungal interactions, illustrated by examples
sourced from many diverse scientific fields. We consider the general and specific
properties of these interactions, providing a global perspective across this emerging
multidisciplinary research area. We show that in many cases, parallels can be drawn
between different scenarios in which bacterial-fungal interactions are important. Finally,
we discuss how new avenues of investigation may enhance our ability to combat,
manipulate, or exploit bacterial-fungal complexes for the economic and practical benefit
of humanity as well as reshape our current understanding of bacterial and fungal ecology
(Frey-Klett et al., 2011). Hence there is an urgent need to discover a novel drug that can
successfully inhibit mycotoxin accumulation in food without the health concerns.
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Researchers have tried different methods and the long-term goal is to understand how
bacteria-fungal interactions influence to produce aflatoxin inhibitory molecules
biosynthesis to discover novel molecules to eliminate aflatoxin accumulation in nature.
Our recent study (Gummadidala et al., 2016) has shown that the marine gramnegative bacterium, Vibrio gazogenes, which notably does not share the same ecological
niches as aflatoxin producers, can produce metabolites that we termed ‘aflatoxin response
metabolites’ (ARMs), which could result in partially (~2-3 fold) inhibit aflatoxin
biosynthesis. However, a direct interaction study between V. gazogenes with an aflatoxin
producer has not been conducted thus far. Hence in this study, we sought to further examine
the aflatoxin inhibiting capacity of V. gazogenes by directly introducing the Vibrio cells in
the A. flavus growth medium.
We present here the results from the Vibro-Aspergillus interaction experiments. Not
only did the Vibrio cells result in almost complete inhibition of aflatoxin, but it also resulted
in significant down-regulation of aflatoxin biosynthesis at the level of transcription
activation of aflatoxin genes. Our data also revealed that, the dead and live V. gazogenes
cells have similar aflatoxin inhibitory effects. We further conducted microscopic imaging
and observed the uptake of V. gazogenes into endosomes like compartments in A. flavus.
These data represent the possibility of the Vibrio cells perturbing the endosomal functions.
The data also uncover the yet unstudied concept that V. gazogenes mechanism of aflatoxin
inhibition occurs at the cellular level as well as at the gene level. Finally, our study has
opened the door of understanding the bacteria-fungal and gene-level interactions which
help us to inhibit the aflatoxin production and pathogenicity of plant and human pathogen
Aspergillus flavus.
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2.2 MATERIALS AND METHODS
2.2.1 Strains, media, and culture conditions
The fungus Aspergillus flavus wild type strain, CA14PyrG.1 (designated as CA14
hereafter), was used for this study. The strain was grown on 100 mm Petri dishes containing
potato dextrose agar by inoculating 2x104 spores in the center containing 10 mL of PDA
and incubated in the dark at 29°C for 2 weeks. Fresh spores collected from these colonies
were used for all the experiments in this study. In these experiments the fungus was grown
in yeast extract sucrose (YES); a rich growth medium (containing 2% w/v yeast extract,
6% w/v sucrose, pH 5.8), by inoculation of 0.5x106 spores per 50 mL of liquid medium
and incubated in a dark orbital shaker at 29°C at 150 rpm.
The bacterium Vibrio gazogenes ATCC 43942 (Farmer et al., 1988), that was
originally isolated from seawater, was grown in Difco Marine Broth (cat # 2216, BD
Biosciences, Sparks, MD, USA) at 29°C in a shaking incubator (150 rpm) for 24 h by
inoculating 105 colony forming units (cfu) /100 ml of growth medium.
2.2.2 Growth quantifications of A. flavus and V. gazogenes
All fungal growth in liquid media was quantified by using dry weight
measurements. Briefly, the mycelia were filtered out of the growth media using a Miracloth
(Millipore, Billerica, MA) and dried at 80°C for 6 hrs and the final weight was recorded.
A. flavus growth on PDA media plate was estimated by measuring the mycelial colony
diameter daily. After 9 days of incubation time, spores were manually collected from PDA
plates using 1xPBS with 0.01% tween and resuspended in 50% glycerol. Spores were
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counted using a haemocytometer. All Vibrio growth measurements were performed using
absorbance readings of growth media at 600 nm. An absorbance of 1.2 on the UV/Vis
spectrophotometer was considered as 106 cells/ml bacterial cell density and calculations
were performed for 16 million bacterial cells appropriately.
2.2.3 Aflatoxin extraction and quantification
Since previous studies (Chanda et al., 2010) that have employed the fungal growth
conditions used in the current study have shown that, aflatoxin biosynthesis and export into
the growth medium occurs at peak levels at 40 h from the point of inoculation of fungal
spores, we have performed all aflatoxin measurements in this study at 40h time-points.
Aflatoxin was extracted from A. flavus cultured YES liquid media by using our standard
chloroform-methanol extraction protocol (Kenne et al., 2018). According to this method,
an equal volume of chloroform added to harvested media, and the organic layer was
collected. Chloroform was evaporated from the organic layer and the residual aflatoxin was
resuspended in 1 ml of 70% methanol. The resuspended aflatoxin extract was spun down
at 15,000 rpm for 1 min at room temperature to remove extra debris from the media and
mycelia. Aflatoxin was quantified in the extracts using ELISA and HPLC procedures as
described previously (Gummadidala et al., 2019a). For analyzing aflatoxin using the
Neogen Veratox Aflatoxin ELISA kit (cat # 8030) from Neogen (Lansing, MI, USA) and
measured on a Stat Fax 4700 Microstrip Reader (Awareness Technologies, Palm City, FL,
USA) as per kit’s protocols. The ELISA has 2 ppb and 50 ppb as lower and upper limits of
detection respectively. Thus, highly concentrated aflatoxin samples were diluted to fit
within the detection range.
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2.2.4 RNA extraction, purification, and cDNA synthesis
Total RNA was extracted from fungal cells harvested at 24h, 30h, and 40h postinoculation in triplicates using a TRIzol-based (TRI Reagent®; cat # T9424, Sigma,
Carlsbad, CA, USA) method as described previously (Gummadidala et al., 2016). The
harvested mycelia were ground with a mortar and pestle in liquid nitrogen. The cold
powdered mycelia were mixed with TRI Reagent® and chloroform and the mix was spun
down at 10,000 rpm for 10 min at room temperature. The organic layer was mixed with
equal volumes of isopropanol and incubated on ice for 15 min and later centrifuged at
10,000 rpm for 15 min at room temperature. The precipitated crude RNA was washed with
70% ethanol and resuspended in RNAse/DNAse free water (Sigma, Carlsbad, CA, USA).
Within 24 h of extraction, RNA cleanup was performed using a Qiagen RNEasy Cleanup
Kit (Qiagen, Valencia, CA, USA), as per kit’s instructions and samples were stored at
−80°C. Total RNA was then reverse transcribed to cDNA using iScript™ cDNA Synthesis
Kit (BioRad Laboratories, Hercules, CA, USA) as per kit’s instructions. All samples were
checked for concentration and purity after each step using a NanoDrop 2000
Spectrophotometer (Thermo-Fisher Scientific, Waltham, MA, USA). All cDNA samples
were stored at −20°C until subsequent RTPCR quantification.
2.2.5 Transcript analysis by Quantitative Real-time PCR
Quantitative RT-PCR (qRT-PCR) was performed using SYBR Green I chemistry
and CFX96 Real-Time PCR detection system (Bio-Rad). A pre-incubation at 95°C for 3
min, dye activation at 95°C for 10 s, primer annealing at 55°C for 30 s, elongation at 55°C
for 50 s followed by a dissociation curve from 65°C to 95°C for 30 min (with 0.5°C
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increments). The primers used for qRT-PCR are provided in Table 2.1. Gene-specific
forward and reverse primers were designed using Primer3 online software (Ye et al., 2012).
All RT-PCRs were performed in triplicate for each gene per sample. The 18s ribosomal
DNA was used as a reference gene in the gene analysis. The gene expression values of A.
flavus obtained from the threshold cycle values were normalized to the 18s rDNA of each
sample. We choose 24, 30 and 40 h to study the transcripts of the genes (explained later in
results). For the quantitative comparison of gene expressions, the values for each target
gene at 30 h and 40 h were expressed as fold change relative to the 24 h time point of that
specific treatment condition. Gene expression was normalized by ΔΔCT analysis (Livak
and Schmittgen, 2001) to A. flavus β-tubulin gene (AFLA_068620) using the gene
expression analysis software package (Bio-Rad CFX Maestro) of the Bio-Rad CFX96. A
significant change in gene expression was considered if fold change was ≥ 2 and the pvalue was < 0.01.
2.2.6 Statistical analysis
All statistical tests were performed using GraphPad Prism Software (GraphPad,
CA, USA). All experiments were performed in triplicate. Microsoft Excel was used to
generate graphs, perform statistical analysis, and calculate significance for dry weight
measurements and aflatoxin analysis. Statistical analyses to determine for statistical
significance of differences between control versus experimental groups were determined
using one-way ANOVA (with sample size 3). Significance was set at p < 0.05. RT-PCR
statistical analysis was performed using CFX Manager software with parameters set for
significance at p-value <0.01 and gene expression fold change ≥ 2.
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2.3 RESULTS
2.3.1 Introduction of the phenomena - V. gazogenes dependent aflatoxin reduction
I first sought to examine the toxigenicity of A. flavus (CA14) in response to 16
million V. gazogenes cells, when added to YES liquid media for 40 h as we found that at
40 h time-point A. flavus grow most vigorously and produce the highest amount of
aflatoxin. We also try to understand if V. gazogenes internalized within hyphae during the
inhibition of aflatoxin production. So, we determined whether bacterial cells were taken up
by the growing mycelia. The uptake was clearly visible after 40 h time-point as the mycelial
pellets showed similar orange-red color as V. gazogenes (Figure 2.1A). Harvested mycelial
pellets that were grown in presence V. gazogenes showed a clear change of their original
(Figure 2.1B). We also conducted a time-course measurement of the bacterial
concentrations in the growth medium by recording the OD600 readings to determine if,
during the mycelial growth, the bacterial cells were depleted in the growth media. As
shown in Figure 2.1C, OD600 dropped steadily from 0h to 40h time-point, post-inoculation.
By 40h time-point, OD600 readings were similar to that of the uninoculated growth medium,
suggesting that V. gazogenes was taken up by the mycelia. Bright-field microscopy clearly
showed bacterial components in discrete locations along the hyphae (spotted as orange dots
using a regular camera in figure 2.1D-i). Hyphal micrographs observed with confocal laser
scanning microscopy with a monochromatic camera suggested that the bacterial
components were within the hyphae in endosome-like compartments (Figure 2.1D-ii). We
also observed from our ELISA data (Figure 2.1E) that the administration of 16 M bacterial
cells resulted in an almost complete inhibition (>98%) of aflatoxin production in liquid
growth media while V. gazogenes was completely taken up by the fungal mycelia. To
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further understand how aflatoxin production in A. flavus is influenced upon V. gazogenes
administration, we have consistently used the same experimental set-up for the rest of this
study with the administration of 16 M V. gazogenes cells.
2.3.2 V. gazogenes viability is not necessary for V. gazogenes - dependent aflatoxin
reduction
Non-viable bacterial biomass had proven to be better and safer bio adsorbent for
contaminants in the environment and is much preferred due to lack of nutrients and cultural
conditions (Zeroual et al., 2006). Given that we did not find any evidence of intact
bacterium on the surface and inside of the fungal cells, we hypothesized that the viability
of V. gazogenes was not essential for V. gazogenes -dependent aflatoxin reduction. To test
this hypothesis, we sought to determine if heat-treated non-viable V. gazogenes could result
in a similar reduction of aflatoxin production in CA14 as the viable V. gazogenes. We
boiled the bacteria at 100OC for 10 min in a hot plate to make them unviable (bacterial cells
were tested by inoculation into fresh marine broth media and observed for growth using
spectrophotometric analysis over the next 40 h and confirmed the no growth of the V.
gazogenes cells). 16 million dead or non-viable V. gazogenes cells were used to treat A.
flavus and aflatoxin synthesis were observed. The scheme for this experiment is shown in
figure 2.2A. The results of this experiment are shown in figure 2.2B, where we observed
an almost complete inhibition of aflatoxin production (>95%), thereby confirming our
hypothesis that V. gazogenes viability is not essential for V. gazogenes -dependent aflatoxin
inhibition and non-viable and viable V. gazogenes cells almost equally inhibit aflatoxin
biosynthesis.
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2.3.3 Vibrio gazogenes dependent aflatoxin reduction occurred at the levels of aflatoxin
gene expression
As a first step to determine the mechanisms underlying Vibrio gazogenes dependent aflatoxin reduction, we determined whether the V. gazogenes treatment was able
to restrict aflatoxin biosynthesis at the level of transcription activation of aflatoxin genes.
Hence, we measured transcript levels of the aflatoxin pathway regulator gene (aflR) and
three aflatoxin pathway genes, pksA (aflC), nor-1 (aflD) and ver-1 (aflM) at 24h and 40h
time-points; the 24h corresponds to activation of aflatoxin biosynthesis and 40h correspond
to the time-point when aflatoxin biosynthesis reached peak levels. The aflatoxin
biosynthesis genes get activated by 24 h with transcript accumulation at 30 h and by 40 h
the fungus is producing copious amounts of aflatoxin in YES liquid growth media (Roze
et al., 2007) which make us to choose 24 h and 40 h time-point to study the transcripts
levels of aflatoxin pathway genes. As shown in Figure 2.3A, while at 24h, we observed a
significant downregulation of three of the four aflatoxin genes (with aflR showing greater
than 2-fold reduction of gene expression), at 40h time-points we observed a significant
reduction of transcript levels (>4-fold) of all four genes analyzed (Figure 2.3B).
2.4 DISCUSSION
I have brought forward through this study, a novel phenomenon – V. gazogenes
dependent aflatoxin reduction in A. flavus, that can allow us to study the uptake
mechanisms of V. gazogenes cells through fungal hyphae. Using confocal laser
microscopies, we observed the uptake of the bacterium by the fungus into endosome like
compartments. The first and essential step for a bacteria-fungal interaction is the physical
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contact and attachment of the bacterial cell with the cell surface of fungi (Rossmann et al.,
2020). In bacterial cells, these interactions often result in the membrane and cellular
damage occurring from multiple factors that include the release of metal ions near the
membrane, membrane rupture, and leakage (Wolfson et al., 2020). These interactions
enable the internalization of the bacterial cells into the fungal cells (Siahmoshteh et al.,
2016). Endocytosis is the most common mechanism of internalization of bacterial cells
(Erktan et al., 2020; Kim et al., 2017), which can be clathrin-dependent (Cossart and
Helenius, 2014; Veiga and Cossart, 2006) and receptor-mediated (Cossart and Helenius,
2014). Once in endosomes, the NPs can travel within cells using the available cellular
machinery for endosomal transport (Bonazzi and Cossart, 2006). In a protoplast isolation
and feeding experiment, the researcher showed that aflatoxin synthesis was happening in
vesicles termed aflatoxisomes, which are endosomal like compartments (Chanda et al.,
2009a; Chanda et al., 2009b). Previous researchers from our lab also showed V. gazogenes
cells uptake by fungal endosomes using SEM and TEM microscopies (Gummadidala,
2018). In this research study, we have obtained clear evidence demonstrating that uptake
of V. gazogenes into Aspergillus hyphae and this uptake resulted in significant aflatoxin
reduction. Additionally, our observations from confocal microscopy support our theory
that endocytosis is one key mechanism for bacterial uptake. Based on the results of this
study, we propose a theoretical model (Figure 2.4) that represents a possible bacteriafungal interaction model for V. gazogenes-dependent aflatoxin reduction. According to this
model, the internalization of cellular components of V. gazogenes in hyphae results in the
intervention of endosomal functions associated with aflatoxin biosynthesis.
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Administration of equal concentrations of heat-inactivated non-viable V.
gazogenes cells to the growth medium resulted in a similar reduction in aflatoxin
production, supporting that bacterial viability was not necessary for this inhibitory effect.
Previous researcher RT-PCR data revealed controversial gene expressions of aflatoxin
pathway genes and global secondary metabolite regulatory genes in the presence of viable
and non-viable V. gazogenes. Their data suggest that the viable and non-viable V.
gazogenes aflatoxin inhibitory mechanisms are different (Gummadidala, 2018). In the
future, it will need further investigation to demonstrate the effect of non-viable V.
gazogenes mediated aflatoxin inhibition at the level of transcriptional activation of
aflatoxin genes.
Since biosynthesis of aflatoxin occurs primarily in endosomal compartments
(Chanda et al., 2009a; Lim and Keller, 2014b; Linz et al., 2012), we were curious to know
if the Vibrio-dependent reduction of aflatoxin was at the level of cellular regulation only.
Hence, we analyzed the expression levels of aflatoxin genes in the presence and absence
of V. gazogenes, with the understanding that if inhibition of aflatoxin occurred only at the
level of cellular regulation, there would be no significant difference of transcript levels of
aflatoxin genes. However, to our surprise, we observed significant down-regulation
(>90%) in the expression of all three aflatoxin genes (nor-1, pksA, and ver-1) and the
aflatoxin pathway regulator aflR analyzed in this study, thereby demonstrating that
aflatoxin inhibition occurred at the level of transcriptional activation.
Our study provides the first evidence, to the best of our knowledge, of an organism
that demonstrates the ability to synthesize aflatoxin inhibitors, while not sharing ecological
niches with aflatoxin producers at all. With the global changes in climate, Vibrio gazogenes
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may be a chemically-gifted organism that has genetically evolved with the rising
mycotoxin levels in the environment (Gummadidala et al., 2016; Kolpin et al., 2014;
Rangel et al., 2015).
One important limitation of the theoretical model proposed here is that it is
primarily founded on studies with one plant pathogen model. The endosomal localization
of bacterial cells upon uptake is hypothesized because some of our preliminary unpublished
data are in line with these findings. While we cannot rule out the possibility of localization
of the bacterial cells in other subcellular organelles, especially cytoplasm, we also point
out that pathogens within the genus Aspergillus, such as A. parsiticus, A. nidulans, A.
fumigatus, and A.oryzae, have consistently been used as a filamentous fungal model and as
a eukaryotic model to study fundamental cellular processes; most eukaryotic cellular
processes are conserved in these models. We also bring to the readers’ attention that the
bacteria-fungal interaction model proposed is an attempted simplification of a possible
complex response of a fungal cell to bacterial cells uptake and is focused on endosomal
intervention only. However, given that the development of endosome to a toxisome
involves a significant cross-talk of multiple organelles (including, but not limited to the
endoplasmic reticulum, mitochondria, and peroxisomes) and vesicles from multiple protein
sorting pathways, an endosomal intervention should affect the functions of other organelles
as well and should be taken into account. As a first step to better utilize V. gazogenes as
inhibitors of fungal toxins and virulence factors, it is essential to increase our understanding
of (1) how V. gazogenes internalize into the endosomes, (2) how it affects the biochemical
fate of endosomes, and (3) how the molecular processes critical to mycotoxin production
and virulence influenced by the altered internalized V. gazogenes. The use of integrated
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multi-omics (genomics, transcriptomics, proteomics, and metabolomics) approaches
involving parallel experimental and computational aspects that will aim to identify the
genes, proteins, and biochemical mechanisms associated with A. flavus response to V.
gazogenes cells should provide a deeper understanding of the metabolic and regulatory
networks of fungal cell systems that are the key player in bacteria -fungal interactions.
Table 2.1: List of PCR primers used in the study
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Figure 2.1: Fungal uptake and the effects of V. gazogenes treatment on aflatoxin levels in
A. flavus. (A) Visual comparisons of mycelial pellets in growth medium without Vg (left
flask) and with Vg (right flask) and, (B) Depletion of bacterial cells in the growth medium
post spore inoculation. Bacterial density in the growth medium as quantified by measuring
the optical density of the growth medium at 600nm (OD600). (C) A photograph of harvested
mycelial pellets that were grown in presence of Vg, (D) Brightfield images of CA14 hypha
upon completion of Vg uptake after 40h growth; i) widefield micrograph captured with a
digital microscope, yellow arrows indicating compartments with bacterial components ii)
Confocal laser scanning micrograph captured with a monochromatic camera, red arrows
indicating compartments carrying bacterial components, and (E) Total aflatoxin production
per mycelial dry weight by A. flavus CA14 in liquid yeast extract sucrose (YES) growth
media in presence and absence (denoted here as Control) of Vg. 16M (16x104 cells/mL
medium) were used for the study. Aflatoxin was quantified by ELISA assay after 40 h timepoint. The values in the y-axis show the aflatoxin levels relative to the corresponding
controls. Error bars represent SEM, from triplicate experiments. Statistical significance of
two-tailed p-values determined using an unpaired t-test for n=16. (*, p<0.05). Star
indicates significance.

35

Figure 2.2: Effect of non-viable or dead V. gazogenes (denoted in figure as Vg) cells on
aflatoxin production by A. flavus. (A) Systematic diagram of treatment procedure of A.
flavus (CA14) by dead V. gazogenes cells (B) Total aflatoxin production per mycelial dry
weight by A. flavus CA14 in yeast extract sucrose (YES) growth media in presence and
absence (denoted here as Control) of Vg. 16M (16x104 cells/mL medium) were used for
the study. The values in the y-axis show the aflatoxin levels relative to the corresponding
controls. Error bars represent SEM, from triplicate experiments. Statistical significance of
two-tailed p-values determined using an unpaired t-test for n=16. (*, p<0.05)
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Figure 2.3: Influence of V. gazogenes on the expression of aflatoxin genes in A. flavus. (A)
Comparison of expressions of genes aflC, aflD, aflM, and aflR in the control and V.
gazogenes administered mycelia at 24 h time-point post-inoculation, and (B) comparison
of the same genes at 40 h time-point post-inoculation. Error bars represent SEM, from
triplicate experiments. Statistical significance of two-tailed p-values determined using an
unpaired t-test for n=3. (**, p<0.05)
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Figure 2.4: A possible bacteria-fungal interaction model for V. gazogenes- mediated
growth-independent inhibition of secondary metabolism. (A) Proposed model. We
hypothesize that V. gazogenes localize in endosomes after up taking by fungal cells. The
endosomes, therefore, provide a platform for interactions between the bacteria and the
endosomal contents: endosomal enzymes and the mycotoxin pathway intermediates. The
interactions influence the molecular and biochemical mechanisms that drive the endosomal
aflatoxin production. Based on our published studies (Gummadidala, 2018), the uptake of
V. gazogenes into cells is determined by the transformations in the extracellular
environment in contact with cells. Our unpublished confocal microscopy images of
Aspergillus flavus cells exposed to V. gazogenes suggest that the bacteria internalize by
early endosomes into the cells.
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CHAPTER 3
INFLUENCE OF Vibrio gazogenes TREATMENT ON HYPHAL
MORPHOGENESIS OF Aspergillus Flavus
3.1 INTRODUCTION
A. flavus is a well-known human pathogen that causes broad-spectrum diseases,
which range from elevation of hypersensitivity to angio-invasive infections to causing
invasive and non-invasive aspergillosis (Hedayati et al., 2007a; Morgan et al., 2005). Along
with Aspergillus fumigatus, A. flavus is associated with allergic bronchopulmonary
aspergillosis (ABPA) (Pihet et al., 2009; Sandhu et al., 1979; Schubert, 2009; Sehgal et al.,
2018). A. flavus is used as model fungal pathogens for understanding the mechanisms of
fungal pathogenicity since it causes invasive Aspergillosis which is the leading cause of
infection-related mortality in the immunocompromised population. A. flavus is the primary
producer of aflatoxin, which is classified as a Group 1 human carcinogen by the
International Agency for Research on Cancer (Gummadidala et al., 2016; Mitra et al.,
2017). Aflatoxin exposure and hepatitis B and C virus infection are reported to be
widespread and act synergistically to cause liver cancer (Tang et al., 2018). Given that
aflatoxin is a common contaminant of weaning foods in parts of the world where childhood
stunting is prevalent, it is essential to reduce aflatoxin exposure in foods consumed by
children (Chen et al., 2018a). There is significant epidemiological evidence that human
aflatoxin exposure is linked to the HIV/AIDS epidemic and the incidence of other
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infectious diseases (Mak et al., 2018). Chronic low-level exposure to carcinogenic
aflatoxins is a serious potential health threat in the US (Magnussen and Parsi, 2013) and
the annual aflatoxin management alone costs $276 - $709 million (CAST, 2003a).
Consequently, innovative evidence-based technologies are urgently required to
minimize aflatoxin exposure. Thus far, biological control has been developed as the most
innovative potential technology of controlling aflatoxin contamination in crops, which uses
the competitive exclusion of toxigenic strains by non-toxigenic ones. In our previous study
we already introduced an effective non-pathogenic novel biocontrol agent (Vibrio
gazogenes), which can inhibit aflatoxin production in A. flavus when the bacteria
internalized through endocytosis (vesicular uptake) by the fungus. Due to bacteria-fungal
interaction, bacterial active invasion by fungal cells can be happened along with
endocytosis. The involvement of endocytosis in the apical growth of fungus hyphae, in the
exchange of signaling molecules during the interaction of fungal cells with other microbes
or plants, are studied (Moebius et al., 2014). Recent evidence has shown that hyphal growth
not only depends on polarized secretion but also requires endocytosis, suggesting that the
recycling of the membrane and sorting of vesicles is required for the fast elongation of
hyphal tubes (Pruyne and Bretscher, 2000). Hyphal growth of filamentous fungi requires
microtubule-based long-distance motility of early endosomes (Steinberg, 2014). Key
players on the molecular level that direct tip growth and endocytosis in the fungal hyphae
based on differential regulation of the actin cytoskeleton (Wendland and Walther, 2005).
Due to our Vibro-Aspergillus interaction experiments, we found almost complete
inhibition of aflatoxin when the bacteria internalized through endocytosis (vesicular
uptake) by the fungus. So, we did some more relative experiments to observed sclerotia
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formation, hyphal polarization, and hyphal fusion etc. in A. flavus. Our experiments
resulted in significant changes in hyphal development that could be related to the
possibility of the Vibrio cells perturbing the endosomal functions. Also, we report here a
set of intriguing alterations in hyphal development upon the Vibrio treatment that
demonstrates the feasibility of using this experimental setup as a novel minimal cell
perturbation approach for investigating how secondary metabolite synthesis and hyphal
development are coordinated in filamentous fungi.
3.2 MATERIALS AND METHODS
3.2.1 Strains and culture conditions
The Strains used in this research are listed in Table 3.1 and stored as glycerol stocks
at -80°C. Vibrio gazogenes, ATCC 43942, was used in this study and was grown in Difco
Marine Broth 2216 (BD Biosciences, Sparks, MD, USA) at 28°C in a shaking incubator
(150 rpm) for 24h before harvesting the cells for the interaction experiments. Aspergillus
flavus wild type strain, NRRL 3357, was used in most of the interaction studies with V.
gazogenes. We have used a norA mutant of A. flavus (MAEW4) that has a block in the
aflatoxin pathway resulting in an accumulation of the orange-colored aflatoxin
intermediate, norsolorinic acid when aflatoxin pathway is activated. YES (6% sucrose, 2%
yeast extract, pH 5.8) medium was used for experiments with liquid culture, and potato
dextrose agar (PDA) was used for experiments with solid culture. All auxotrophic strains
were grown on glucose minimal medium (GMM) for spore production at 29°C. In some
experiments using the pyrG auxotrophic strain, TJES 19.1, 0.56 g/L uracil, and 1.26 g/L
uridine were supplemented and for the argB auxotrophic strain, TJES 20.1, 1 g/L arginine
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was supplemented in the growth medium. In some cases, all three supplements were added
as described below. Heterokaryon analysis was assessed on GMM+0.25% Triton X-100
medium.
3.2.2 Radial growth, spore production, and sclerotial formation
To estimate the radial growth of the strains, the diameter from leading hyphae on
either side of the spore point inoculated plate of PDA and GMM was measured every day
for 7 days and the experiment triplicated. Fungal growth in liquid media was quantified by
using dry weight measurements. Briefly, the mycelia were filtered out of the growth media
using a Miracloth (Millipore, Billerica, MA) and dried in an oven at 80°C for 6 h and the
weight difference before and after drying was recorded. Spore production was assessed by
creating a spore overlay. 10 mL of PDA cooled to solidify, and 106 cells/ml were center
inoculated and grown at 30°C for one week. At the respective time point, spores were
manually collected from PDA plates with the help of sterilized spreader by gently rubbing
and homogenized in 3 ml 1xPBS with 0.01% tween and resuspended in 50% glycerol.
Spore solutions were enumerated via hemocytometer and performed in triplicate.
The sclerotial formation was assessed on PDA media. 107 cells/ml were center
inoculated on 100 mm PDA plates containing. These were incubated in the dark for 5 days,
washed with 70% ethanol, sclerotia scrapped off, and weighed. The experiment was
performed with four replicates.

42

3.2.3 Hyphal fusion assay and Heterokaryon formation
Hyphal fusion assay was assessed as previously reported (Zhao et al., 2017b).
Briefly, the pyrG auxotroph TJES19.1, argB auxotroph TJES20.1, and mutant ΔhamI TXZ9.16 were grown on GMM with supplements. To investigate if V. gazogenes treatment
interfered in the hyphal fusion process, we mixed equal numbers of the pyrG auxotrophic
strain (TJES 19.1) with argB auxotrophic strain (TJES 20.1) were spotted onto the GMM
agar media containing arginine (1 g/L) and uracil (5 mM)/uridine (5 mM) with or without
V. gazogenes. After incubation at 29°C for 5 days, the newly formed conidia were
collected, and 105 conidia were spread onto the GMM+0.25% Triton X-100 medium with
no added supplement (the 0.25% Triton X-100 restricts colony diameter to help with
precise colony counts). Heterokaryotic colonies were counted after incubation for 3 days
at 29°C. As a negative control we used a cross of the hyphal anastomosis mutant, ΔhamI TXZ9.16, with TJES 20.1. This experiment was performed with triplicates and repeated
twice.
3.2.4 Aflatoxin analysis
Aflatoxin was extracted from liquid cultures and solid cultures using our standard
chloroform-methanol extraction protocol described previously (Kenne et al., 2018).
Aflatoxin was quantified in the extracts using a Veratox for Aflatoxin ELISA kit (Neogen
Food Safety, Lansing, MI, USA) and measured on a Stat Fax 4700 Microstrip Reader
(Awareness Technologies, Palm City, FL, USA) and using HPLC procedures as described
previously (Gummadidala et al., 2019b).
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3.2.5 Statistical analysis
GraphPad Prism software (La Jolla, CA, United States) was used for statistical
analysis. Statistically significant differences were determined by ANOVA and P < 0.05.
The error bars in all figures indicate the standard error of the mean. All experiments were
performed in triplicate.
3.3 RESULTS
3.3.1 V. gazogenes dependent aflatoxin inhibition associated with sclerotial formation
Conidia and sclerotia contain aflatoxin (Wicklow and Shotwell, 1983) and studies
have positively correlated sclerotial development with aflatoxin production (Brown et al.,
2009) although one process is not necessarily dependent on the other (Chang et al., 2016;
Chang et al., 2017). Since we observed V. gazogenes have an impact on aflatoxin
production and we found its components in organelles that appeared to be endosomes
(Gummadidala, 2018), we proceeded to test whether, sclerotia development is restricted,
in a V. gazogenes -dependent manner. For comparative quantification of sclerotia in the
presence and absence of Vg, we have used a norA mutant of A. flavus (MAEW4) that has
a block in the aflatoxin pathway resulting in an accumulation of the orange-colored
aflatoxin intermediate, norsolorinic acid, when aflatoxin pathway is activated. We used this
strain for this experiment because it would allow us to visualize the sclerotia side-by-side
with norsolorinic acid. As shown in figure 3.1A, we observed significant depletion of
sclerotia numbers in the areas where the fungi interacted with V. gazogenes; in the areas
where red-colored V. gazogenes was present, norsolorinic acid depletion (absence of
orange color) and a significant drop in sclerotia was clearly visible. After counting the
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sclerotia, we observed a smaller number of sclerotia development in the treated area rather
than the untreated area of the MAEW4 plate (Figure 3.1B).
3.3.2 V. gazogenes administration impeded hyphal elongation and resulted in the earlier
development of conidia
In consistence with our theory that V. gazogenes components upon internalization
within hyphae, intervene in normal endosomal functions, we have also observed that
hyphal elongation, a process that also relies on endocytosis and normally functioning
endosomes, was significantly inhibited (by ~3-fold) in a V. gazogenes-dependent manner
(Gummadidala, 2018). Simultaneously, we observed an early asexual development (~2.5fold higher conidia, as shown in figure 3.2A. To our surprise, these conidia, when grown
back on PDA plates, produced significantly (~2 -fold) less aflatoxin that conidia collected
from untreated NRRL 3357 colonies (Figure 3.2B).
3.3.3 V. gazogenes dependent aflatoxin inhibition associated with depletion of hyphal
fusion
Since we observed V. gazogenes components in organelles that appeared to be
endosomes, we proceeded to test whether hyphal fusion, a fundamental biological process
of filamentous fungi, and which is coordinated by the endocytic machinery and endosomal
transport (Fischer and Glass, 2019; Riquelme et al., 2018), is impeded in a V. gazogenes dependent manner. We used a recently published hyphal fusion assay (Zhao et al., 2017a;
Zhao et al., 2017b) that is based on the rationale that since heterokaryon formation requires
hyphal fusion, any intervention of hyphal fusion would prevent heterokaryon formation.
The scheme for this experiment is shown in figure 3.3A. Equal numbers of conidia

45

from pyrG auxotroph (TJES 19.1) and argB auxotroph (TJES 20.1) were mixed and grown
on GMM medium supplemented with uracil/uridine and arginine. After 5 days conidia
were spread onto GMM medium lacking supplementation where only conidia generated
from heterokaryons could grow. As shown in figure 3.3 B and C, crosses between TJES
19.1 and TJES 20.1 in the presence of Vg, almost completely inhibited (by >95%)
heterokaryon formation, an observation that was very similar to the negative control
(crosses between the hyphal anastomosis mutant, ΔhamI and TJES 20.1).
3.4 DISCUSSION
We introduce through this study, a novel cellular perturbation tool (Vibrio
gazogenes) that can allow us to study the mechanistic details of how fungal secondary
metabolism and hyphal morphogenesis is coregulated at the level of endosomal uptake and
transport; also from our previous studies, we found that this cellular perturbation does not
lead to growth inhibition (Gummadidala, 2018). To know how aflatoxin synthesis and
hyphal morphogenesis was disrupted in a V. gazogenes dependent manner we conducted
this research. The internalization process of cellular components of V. gazogenes in hyphae
results in the intervention of endosomal functions associated with hyphal morphogenesis
and aflatoxin biosynthesis, was our main target to investigate in our study.
Since biosynthesis of aflatoxin occurs primarily in endosomal compartments
(Chanda et al., 2009a; Lim and Keller, 2014a; Linz et al., 2012), we were curious to know
if the Vibrio-dependent reduction of aflatoxin was associated with sclerotial formation.
Hence, we have conducted an experiment to comparatively quantify sclerotial development
in the presence and absence of the Vibrio treatment by using the norA mutant of A. flavus
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(MAEW4). This strain produces bright orange-red color when aflatoxin pathway activated,
which means the color indicates aflatoxin production visually. We observed that, in the
presence of V. gazogenes, A. flavus (MAEW4) strain cannot produce orange-red color as
well as aflatoxin, and the number of sclerotia was also depleted where we applied V.
gazogenes in PDA plate with MAWE4 strain spreading.
An interesting observation connected with endosomal development, transport, and
functions is the significant drop in hyphal elongation during polar growth upon Vibrio
treatment. It is well established that the regular functioning of endocytic machinery is
needed for hyphal elongation during polar growth (Riquelme et al., 2018; Upadhyay and
Shaw, 2008). Hence, our observation in figure 3.2A (significantly less hyphal elongation)
can support a theory that internalization of the Vibrio components interferes with the
endocytic machinery that regulates polar growth. Another interesting observation was early
conidiation that could be associated with the inhibition of hyphal fusion and reduced
sclerotia development upon Vibrio administration. It is well known Aspergilli maintain a
balance between sexual and asexual development through a cross-talk of light-dependent
regulatory factors, the pathways regulating sexual and asexual reproduction and the
secretion of oleic and linoleic-acid-derived oxylipins known as the psi factor (Chamberlain
and Ingram, 1997; Krijgsheld et al., 2013; Park and Yu, 2012; Tsitsigiannis et al., 2004a;
Tsitsigiannis and Keller, 2007; Tsitsigiannis et al., 2004b; Tsitsigiannis et al., 2005). These
aspects will be investigated in more detail in our follow-up experiments.
Since we had observed the presence of the Vibrio components, albeit not intact
cells, in endosome-like compartments, we were curious to know if these components were
in any way, disrupting endosomal functions. Hence, we have conducted the hyphal fusion
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assay in the presence and absence of the Vibrio treatment. Hyphal fusion occurs within and
between fungal colonies to form heterokaryons that coexist in a common cytoplasm and it
is currently understood that endosomes trafficking to and from the fusion site assist in the
processes that are involved in the fusion (Daskalov et al., 2017; Fischer and Glass, 2019;
Fleißner and Herzog, 2016; Fu et al., 2011; Sánchez-León et al., 2015). We have observed
that the Vibrio treatment prevents the hyphal fusion between the uridine and arginine
auxotroph mutants TJES19.1 and TJES20.1, respectively, resulting in a significant drop in
the formation of heterokaryon containing conidia that could form colonies on GMM. Plates
on which conidia obtained from Vibrio administered plates looked very similar to conidia
obtained from the cross of ΔhamI (TXZ9.16) with TJES20.1 strain. Besides, we were also
able to notice the effects of interruption of hyphal fusion on sclerotia numbers. Sclerotial
development is a process that needs hyphal fusion (Erental et al., 2008), which could
explain the significant drop in sclerotial counts upon Vibrio treatment. Previously
published data show that cellular fusion in A. flavus is most clearly found in the inability
to form heterokaryons or sclerotia. The consequence of heterokaryon formation and
sclerotial loss is also found in decreased ability to synthesize aflatoxin in this strain (Zhao
et al., 2017b). Another study showed that the deletion of the veA gene in A. flavus and A.
parasiticus blocks the production of aflatoxin as well as sclerotial formation (Cary et al.,
2007).
This study, therefore, unlocks a new door for research that can investigate how the
Vibrio uptake into hyphae resulted in the down-regulation of aflatoxin and how this is
linked with the alterations in hyphal morphogenesis that were observed in the current study.
In the long run the research will lead to the discovery of novel cellular targets and
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approaches to mitigate aflatoxin contamination to improve food and feed safety and human
health. Our future studies will involve the use of integrated omics approaches to identify
the molecular and cellular mechanisms coordinating secondary metabolic pathways and
hyphal development that is targeted in the Vibrio-dependent aflatoxin inhibition.
Table 3.1: List of strains used in the study
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Figure 3.1: Influence of V. gazogenes (denoted in figure as Vg) on sclerotial
development of A. flavus. (A) Visual comparisons of MAEW4 colonies in the presence and
absence of Vg. White circle depicts an area with Vg treatment and the yellow circle is an
area without Vg treatment. (B) corresponding sclerotia counts. Statistical significance of
two-tailed p-values determined using an unpaired t-test for n=3. (**, p<0.001). Star
indicates significance.
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Figure 3.2 Influence of V. gazogenes uptake on polar growth, conidiation, and nextgeneration toxicity on A. flavus. (A) Dissection micrographs of sections of growing
colonies of NRRL 3357, untreated and treated with V. gazogenes. Relative polar growth as
measured by comparisons of tip growth measured by an average distance of the tip from
the center of the colony; Relative conidiation was determined by conducting spore counts
after 3days of growth. (B) Comparison of next generation toxicity was determined by
determining total aflatoxin produced by mycelia growth from an equal number of spores
harvested from untreated and V. gazogenes treated NRLL 3357 colonies. Error bars
represent SEM, from triplicate experiments. Statistical significance of two-tailed p-values
determined using an unpaired t-test for n=3. (**, p<0.001). Star indicates significance.
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Figure 3.3: Influence of V. gazogenes uptake on hyphal fusion. (A). Outline of the method
to measure hyphal fusion (based on the method described by (Zhao et al., 2017b)
(B) Photographs of heterokaryon formation or lack of formation in crosses. Plates of mixed
cultures were spread and incubated at 29°C for 3 days. (C) The number of heterokaryotic
colonies formed for each cross. Error bars represent SEM, from triplicate experiments.
Statistical significance of two-tailed p-values determined using an unpaired t-test for n=3.
(**, p<0.001). Star indicates significance.
N.B.: ΔhamI (TXZ9.16) was uracil/uridine auxotrophic; 19.1 (TJES19.1), uracil/uridine
auxotrophic; 20.1 (TJES20.1), arginine auxotrophic.
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CHAPTER 4
UNDERSTANDING THE PROCESS OF FUNGAL UPTAKE OF Vibrio
gazogenes CELLULAR MATERIALS LEADING TO AFLATOXIN
DOWNREGULATION
4.1 INTRODUCTION
Filamentous fungal growth is characterized by an apical extension of the hyphal
cell. This process requires the constant supply of membranes and proteins, such as cell
wall-forming enzymes, to the growing hyphal tip. Endocytosis is common in filamentous
fungi that support fungal morphology (Steinberg, 2014). Endocytosis is a complex process
of absorption from the environment (and subsequent distribution within the cell) of soluble
substances, macromolecules, microparticles, etc. utilizing vesicles developed by the
cytoplasmic membrane (Olga et al., 2017). Bacterial secretomes and pathogens use
endocytosis as a mode of entry to the cell interior (Dutta and Donaldson, 2012). The
majority of reports on cellular uptake mechanisms suggest that endocytosis is the preferred
route of cell entry of nutrients and components from their surrounding environments
(Wattiaux et al., 2000). There are so many endocytosis inhibitors used in different
researches,

for

examples:

natamycin,

dynazor,

Pitstop

2,

nocodazole,

monodansylcadaverine, latrunculin A, nystatin, filipin, etc. used in Rhizoctonia solani
(Olga et al., 2017), the polyene antimycotics nystatin, ﬁlipin and natamycin used in
Penicillium discolor and Aspergillus niger (te Welscher et al., 2010; van Leeuwen et al.,
2013; van Leeuwen et al., 2009).
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Interactions between bacteria and fungi are widespread in nature and play pivotal
roles in ecological and medicinal processes (Frey-Klett et al., 2011). Microbial secondary
metabolites (SMs) have profound impacts on the ability of these microbes to colonize and
survive in complex biotic environments. Microbiome also secretes various proteins into
extracellular milieu which are known as microbial secretomes, under such interactions.
Secretome proteins (e.g., receptors, transporters, adhesins, complex cell structures,
secreted enzymes, toxins, and virulence factors) allow bacteria to interact with and adapt
to their environment (Desvaux et al., 2009; Gagic et al., 2016; Zhou et al., 2010). Bacteria
secrete the proteins by classical pathways like Sec and Tat pathways are known to be
classically secreted proteins (Green and Mecsas, 2016), whereas many proteins that are
found in the supernatant of many bacteria and lack signal peptides are known as nonclassical secreted proteins (Wang et al., 2016). One school of thought suggests their
secretion by some unknown secretion pathway (Zhao et al., 2018), while other supports
that it is the cell lysis that makes these proteins come into the extracellular milieu as the
majority of these proteins are cytoplasmic (Ebner et al., 2016; Oliveira et al., 2012; Zubair
et al., 2020). Many species of bacteria are subject to lysis in the presence of some enzymes
such as lysozyme mediated by other microbes in the same environment. Penicillin sp.
causes the death of bacteria through enzyme-mediated lysis (Nelson et al., 2001).
Lactobacillus casei showed higher anti-aflatoxigenic activity on Aspergillus flavus and
individual antagonism assays, suggesting that the inhibitory activity was due to
extracellular metabolites produced in cell-free supernatant fluids of the cultured broth of
L. casei (Chang and Kim, 2007).
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Prodigiosin, a red color secondary metabolite appears only in the later stages of
bacterial growth produced by many strains of the bacterium Serratia marcescens (Bennett
and Bentley, 2000; Harris et al., 2004), as well as other proteobacteria such
as Vibrio psychroerythrus, Vibrio gazogenes and Hahella chejuensis (Williamson et al.,
2006), Pseudomonas magneslorubra, Serratia rubidaea, Alteromonas rubra, Rugamonas
rubra and

Gram-positive

actinomycetes,

such

as Streptoverticillium

rubrireticuli and Streptomyces longisporus ruber (Elkenawy et al., 2017). The production
of prodigiosin has been observed to be affected by several environmental factors, inorganic
phosphate availability, media composition, temperature, and pH (Williamson et al., 2005).
The number of differential and selective media has been used for the isolation and
production of pigment from Serratia sp. (Darshan and Manonmani, 2015). Vibrio
gazogenes is well-known for its ability to synthesize bactericidal and fungicidal pigments,
magnesidin A (Imamura et al., 1994), prodigiosin and cyclo-prodigiosin (Allen et al.,
1983). Previous studies have also shown that random mutations in this bacterium with 1methyl-3-nitro-l-nitrosoguanidine expanded its metabolic output and activated the
synthesis of additional bactericidal prodigiosin-related pigments, norprodigiosin and
propyl prodigiosin (Alihosseini et al., 2010). Research study showed that aflatoxin
exposure to V. gazogenes diminished prodigiosin released into the growth medium, but
additionally resulted in the production of a new compound that demonstrated the ability to
specifically-inhibit aflatoxin synthesis in the model aflatoxin producer, A. parasiticus
(Gummadidala et al., 2016).
Microorganisms universally attach to and grow on a surface and produce
extracellular polysaccharides, resulting in the formation of a biofilm (Donlan, 2001).
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Biofilm formation, seems likely to provide a substantial survival advantage to aquatic
organisms such as Vibrio species (Yildiz and Visick, 2009). Many studies on this rely on
colony morphology as an indicator of biofilm formation. Flagella, pili, and polysaccharides
are involved in the initial stages of biofilm formation by Vibrio sp. (Nakhamchik et al.,
2008). The capsular polysaccharide (CPS) or exopolysaccharide (EPS) loci involved in
biofilm formation have been identified from numerous Vibrio sp. (Yildiz and Schoolnik,
1999). The Vibrio sp. studied to date produce distinct exopolysaccharides, and some if not
all have the potential to produce multiple types of polysaccharides (Enos-Berlage et al.,
2005). In Vibrio species, regulation of exopolysaccharide production and biofilm
formation is complex, and involves numerous transcriptional regulators, particularly twocomponent signal transduction and quorum sensing regulators (Fong and Yildiz, 2008;
Yildiz et al., 2004). Quorum sensing is an important mechanism by which bacteria and
fungi regulate developmental programs including biofilm formation and expression of
virulence proteins through alteration of gene expression patterns based on population
densities. Fungal secondary metabolites, including those produced by Fusarium spp., are
involved in disrupting quorum signaling in bacteria (Martín-Rodríguez et al., 2014;
Venkatesh and Keller, 2019). The exopolysaccharides are thought to play a significant role
in the colonization of lactic acid bacteria to various ecosystems (Górska et al., 2010).
Research investigating industrial applications is concentrated on the extracellular
polysaccharides, which have simpler extraction and purification processes (Sutherland,
2002). Different methods can be used for extracting exopolysaccharide, among which
ethylene precipitation usually use most (Comte et al., 2006; Ziadi et al., 2018).
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These studies have prompted us to hypothesize that co-culturing V. gazogenes
bacterium in the presence of endocytosis inhibitors (filipin and natamycin) with A. flavus
fungus will have different inhibitory effects on the aflatoxin biosynthesis and the mycelial
growth of A. flavus. In this study, we treated V. gazogenes cells with different media
containing A. flavus only and a combination of A. flavus and V. gazogenes, to investigate
the influence of A. flavus (CA14) in producing lysing enzymes by V. gazogenes. To
understand the mechanism of action of V. gazogenes we further conducted one experiment
where we treated A. flavus with heat mediated non-viable gram-positive and gram-negative
and prodigiosin producing bacteria and observed that other bacteria don’t have same antiaflatoxigenic activity as V. gazogenes. To understand the mechanism of action of intact V.
gazogenes cells we performed an experiment where we treated A. flavus with intact cells
and different fractionated parts of V. gazogenes and surprisingly concluded that the intact
V. gazogenes cells most effectively and efficiently decrease aflatoxin production (>99%)
rather than other fractionated parts of V. gazogenes cells. Definitively our study establishes
a novel cell biological approach for investigating how uptake mechanisms of cellular
components of V. gazogenes leading to aflatoxin down-regulation.
4.2 MATERIALS AND METHODS
4.2.1 Strains, media, and growth conditions
The fungus Aspergillus flavus strain CA14PyrG.1 (designated as CA14 hereafter)
(acquired from USDA Agricultural Research Service, New Orleans, LA, United States)
and bacteria Vibrio gazogenes (ATCC 43942), Serratia sp. (ATCC 39006), Escherichia
coli (ATCC 25922)

Staphylococcus aureus (ATCC 25923), Vibrio harveyi (ATCC
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14126), Vibrio fischeri or Aliivibrio fischeri (ATCC 7744) were used for this study. Yeast
extract sucrose (YES) (2% yeast extract, 6% sucrose; pH 5.8) was used as the liquid growth
medium and potato dextrose agar (PDA) was used as the solid growth media, for A. flavus
for the entire study. Fungal cells were grown for 40 h (as required by experiments) by
inoculating 107 spores per 50 mL of liquid growth medium and incubated at 29°C in a dark
orbital shaker at 150 rpm. For growth of fungal mycelia on solid media, 2x104 spores were
center inoculated on 100 mm Petri dishes containing 10 mL of PDA and incubated in the
dark at 29°C.
Difco Marine broth (cat # 2216, BD Biosciences, Sparks, MD) was used, as liquid
growth media for V. gazogenes and the bacterial cells were grown for 24 h by inoculating
105 colony forming units (cfu) /100 ml of growth medium. The cultures were incubated at
29°C in a dark orbital shaker at 150 rpm. Nutrient broth (NB, cat # 234000, BD) was used
as a liquid growth media for Serratia sp. Small inoculum was grown with 105 cfu/5 ml
liquid growth media and incubated overnight at 26°C in a dark orbital shaker at 150 rpm.
Tryptic soy broth (TSB, cat # 211825, BD Biosciences, Sparks, MD) was used as liquid
growth media for S. aureus, and E. coli. Small inoculum was grown with 105 cfu/5 ml
liquid growth media and incubated overnight at 37°C in a dark orbital shaker at 150 rpm.
At the end of the incubation time, 100,000 cells were taken from the small inoculum and
further used to inoculate 100 ml TSB and incubated for 24 h at 37°C in a dark orbital shaker
at 150 rpm. Difco Photobacterium Broth (DPB, cat # 213050, BD) was used as liquid
growth media for Vibrio harveyi and Vibrio fischeri or Aliivibrio fischeri. Bacterial cells
were grown with 105 cfu/5 ml liquid growth media and incubated for 24 h at 26°C in a dark
orbital shaker at 150 rpm.
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4.2.2 A. flavus treatment with V. gazogenes and endocytosis inhibitors
To know the effect of endocytosis inhibitors in the uptake of V. gazogenes by fungal
mycelia, we conducted an experiment by using two polyene antimycotics or endocytosis
inhibitors named filipin (Sigma) and natamycin (Sigma) in their Minimal Inhibitory
Concentration (MIC) (Van Leeuwen et al., 2010; van Leeuwen et al., 2009). Filipin was
dissolved in 100% DMSO and natamycin in 85% DMSO (Brik, 1981). A 1-mmol l-1 stock
solution of each endocytosis inhibitor was made and used for stepwise dilution. We grew
A. flavus (CA14PyrG.1) in four separate flasks by inoculating 107 spores per 50 mL of YES
medium and incubated at 29°C in a dark orbital shaker at 150 rpm for 40 h. In one flask
we did not add anything, only CA14 growth started. In the second flask, we treated CA14
with V. gazogenes. In the third and fourth flasks, we treated CA14 with V. gazogenes. along
with filipin and natamycin respectively in their 2X Minimal Inhibitory Concentration
(MIC) recommended by (van Leeuwen et al., 2009). For filipin we used 3 µmol l-1 / 50 ml
media and for natamycin we used 6 µmol l-1 / 50 ml media from our previously made 1mmol l-1 stock solution.
4.2.3 Determination of color intensity score
Color intensity score was measured for fungal mycelial pellets in the absence and
presence of V. gazogenes and endocytosis inhibitors (filipin and natamycin) after a 40 h
time point from inoculation (Kaur et al., 2018). The cumulative score was determined by
the color of A. flavus mycelial pellets which indicate the uptake of V. gazogenes cells by
fungal cells in the presence of different endocytosis inhibitors (filipin and natamycin). The
score for the color intensity was based on the following scale where; 0 = white natural A.
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flavus (CA14PyrG.1) mycelial pellets with the absence of V. gazogenes and endocytosis
inhibitors (no uptake of V. gazogenes cells); 10 = red CA14 PyrG.1 mycelial pellets treated
with V. gazogenes but in absence of endocytosis inhibitors. (highest amount uptake of V.
gazogenes cells by CA14PyrG.1). Hence, a higher color intensity score indicates more
uptake of V. gazogenes cells by CA14PyrG.1.
4.2.4 lysis experiment of V. gazogenes in presence of A. flavus
For this experiment, we collected fresh 1 ml YES media (only YES-Y), 1 ml growth
media from 24 h A. flavus (CA14) growth flask (YES+CA14 - YC) and 1 ml growth media
from 24 h A. flavus with V. gazogenes growth flask (YES+CA14+Vg- YCV) respectively
in three separate cuvettes. Then we added 50 µl of fresh 24 h growing V. gazogenes in each
1 ml media, respectively. We measured OD at 600 nm at 0 h, 6 h, and 12 h time points
from each cuvette (Figure 4.1A).
4.2.5 A. flavus treatment with different non-viable bacteria along with non-viable V.
gazogenes
The fungus A. flavus was treated with dead bacteria - V. gazogenes, Serratia sp., E.
coli, S. aureus, V. harveyi, V. fischeri, or A. fischeri. The 24 h bacterial cultures were spun
down at 4000 rpm for 15 min at room temperature and resuspended using YES media. With
the help of absorbance measurements at 600 nm, 16 million cells from a 24 h bacterial
culture (made unviable by boiling at 100OC for 10 min in a hot plate) were sorted out and
added to the 50 ml YES liquid media simultaneous with 5x107 A. flavus spores and
incubated at 29°C in a dark orbital shaker at 150 rpm for 40 h. Comparably 24 h bacterial
cultures of Serratia sp., E. coli, S. aureus, V. harveyi, V. fischeri, or A. fischeri. were spun

60

down at 4000 rpm for 15 min at room temperature and resuspended using 100 x PBS. The
same number of bacterial cells (unviable by boiling at 100OC for 10 min in a hot plate)
were sorted out and added to the 50 ml YES liquid media simultaneous with 5x107 A. flavus
spores and incubated at 29°C in a dark orbital shaker at 150 rpm for 40 h. The loss of
viability in these cells was confirmed before experimentation by confirming their inability
to grow in fresh growth medium. At the end of incubation, A. flavus mycelia were harvested
by filtering the mycelia through a Miracloth (Millipore, Billerica, MA) and the cells
subjected to appropriate processing for various growth measurements and aflatoxin
analysis.
4.2.6 A. flavus treatment with intact V. gazogenes along with different fractionated part of
the V. gazogenes
For conducting this experiment, we grew V. gazogenes in three separate batches for
24 hr, using Difco Marine broth liquid growth media by inoculating 105 colony forming
units (cfu) /100 ml of growth medium. Then, one batch of 24 h bacterial cultures were
centrifuged down at 4000 xg for 15 min at room temperature and discarded the supernatant.
We washed the bacterial cells with ethanol (EtOH) (two-fold volume of cells) at room
temperature followed by centrifugation at 4000 ×g at 25ºC for 15 min. These steps resulted
in the isolation of crude precipitate or washed bacterial cells (white color)(Bajpai et al.,
2016; Paulo et al., 2012). We collected the supernatant which we called washate (red color)
and reduced the volume of washate by evaporating the ethanol. Then we resuspended the
washate in 1mL YES media before adding the cultures to the 50 ml fungal (A. flavus)
growth medium. We also resuspended the crude precipitate or washed bacterial cells (white
color) separately in 1mL YES media before adding the cultures to the 50 ml fungal (A.
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flavus) growth medium. We prepared our second batch of bacterial cultures in the same
manner. But after separating the washate and washed cells, we mixed them and
resuspended the mixture (washate and washed cells) in 1mL YES media before adding the
cultures to the 50 ml fungal growth medium. We directly resuspended our third batch 24 h
bacterial cultures after centrifuging in 1mL YES media before adding the cultures to the
50 ml fungal (A. flavus) growth medium. We allowed all the fungal cultures to grow for 40
h with intact and different fractionated parts of V. gazogenes. At the end of incubation, A.
flavus mycelia were harvested by filtering the mycelia through a Miracloth (Millipore,
Billerica, MA) and the cells subjected to appropriate processing for various growth
measurements and aflatoxin analysis.
4.2.7 Growth measurements of fungus and bacteria
All fungal growth in liquid media was quantified by using dry weight
measurements. Briefly, the mycelia were filtered out of the growth media using a Miracloth
(Millipore, Billerica, MA) and dried in an oven at 80°C for 6 h and the weight difference
before and after drying was recorded. To estimate the growth of A. flavus on PDA media
plates, the spread of mycelial colony was measured daily. After 9 days of incubation time,
spores were manually collected from PDA plates using 1xPBS with 0.01% tween and
resuspended in 50% glycerol. Spores were counted using a haemocytometer. All bacterial
growth measurements were performed using absorbance readings of growth media at 600
nm. An absorbance of 1.2 on the UV/Vis spectrophotometer was considered as 106 cells/ml
bacterial cell density and calculations were performed for 16 million bacterial cells
appropriately.
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4.2.8 Aflatoxin measurements
Aflatoxin was extracted from A. flavus cultured YES liquid media by adding an
equal volume of chloroform in a separating funnel and collecting the organic layer.
Chloroform was evaporated from the organic layer and the residual aflatoxin was
resuspended in 500 µl of 70% methanol. The resuspended aflatoxin extract was spun down
at 15,000 rpm for 1 min at room temperature to remove extra debris from the media and
mycelia. Quantification of aflatoxin for the aflatoxin uptake experiments was performed
using a Neogen Veratox Aflatoxin ELISA kit (cat # 8030) from Neogen Food Safety
(Lansing, MI, USA) and measured on a Stat Fax 4700 Microstrip Reader (Awareness
Technologies, Palm City, FL, USA) as per kit’s protocols. The ELISA has 2 ppb and 50
ppb as lower and upper limits of detection, respectively.
4.2.10 Stereo and bright field microscopy
For light imaging experiments A. flavus has grown a coverslip and treated with V.
gazogenes. For visualization of growing colonies using dissection or stereo microscope
(Leica EZ4), we grew colonies on 10 µl liquid YES media with or without Vibrio
supplementation. For bright-field (Fischer microscope) imaging of hyphae growing in
liquid medium, we used a growing colony generated from spores that were inoculated on
10 µL YES medium containing the V. gazogenes cells.
4.2.11 Confocal laser scanning microscopy
A. flavus hyphae was grown from spores by inoculating in 30 µL YES medium
containing Vibrio cells on a 35 mm glass-bottom fluorescent dish for 6 h. The fungal
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mycelia were fixed using 4% formaldehyde and washed using 1xPBS and 0.05% tritionX100. The resulting mycelia were studied and imaged using Leica TCS SP5 confocal
microscope (Leica Microsystems Inc., IL, USA) at 20x, 40x, and 100x magnification.
4.2.12 Statistical analysis
Statistical analyses for this study were conducted using the GraphPad Prism
Software (GraphPad, CA, USA). Microsoft Excel was used to generate graphs, perform
statistical analysis and calculate significance for dry weight measurements and aflatoxin
analysis. The statistical significance of two-tailed p-values were determined using an
unpaired t-test, using n = 3 and p < 0.01.
4.3 RESULTS
4.3.1 V. gazogenes cannot inhibit aflatoxin production in the same manner in A. flavus in
the presence of endocytosis inhibitors (filipin and natamycin)
We sought to understand if V. gazogenes cells internalized and uptaken within
hyphae in endosome-like compartments through endocytosis during the inhibition of
aflatoxin production. To understand the effect of the uptake of V. gazogenes cells along
with endocytosis inhibitors (filipin and natamycin) on A. flavus growth and aflatoxin
synthesis, we treated A. flavus (in YES liquid media) with 16 million V. gazogenes cells
for 40 hours with filipin and natamycin separately by using their Minimal Inhibitory
Concentration (MIC) (Van Leeuwen et al., 2010). After harvesting the A. flavus mycelia at
40 h time point, we investigated if the mycelial color differed in the presence of endocytosis
inhibitors. From our previous studies we found that, V. gazogenes bacterial components
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were internalized within the hyphae in endosome-like compartments (Gummadidala,
2018). So, we initially checked the color of fungal mycelia by visualizing them using a
stereo-microscope (Leica EZ4), which will help us to understand that the V. gazogenes
cells uptake by fungal mycelial pellets was hampered with the presence of endocytosis
inhibitors or not because if the uptake of bacterial cells is happening through endocytosis,
then it will definitely reduce in presence of endocytosis inhibitors. Stereo microscopy
clearly showed the color difference between different treatments (Figure 4.1A). The fungal
mycelial pellets were dark red in color which were treated with only V. gazogenes, but the
color eventually reduced in the presence of filipin and natamycin, respectively. We also
found the color intensity score lower in presence of filipin which was 5.9 ± 0.15 and in
presence of natamycin which was 3.2 ± 0.09, based on our color intensity scale: 0 (Whitish
color A. flavus cell) -10 (dark orange-red color due to the presence of Vibrio cells) (Figure
4.1B).
The aflatoxin levels analyzed using the ELISA technique showed that there were
nearly undetectable levels of aflatoxin in the YES liquid media in the presence of V.
gazogenes (irrespective of cellular concentration) as compared to the untreated control. We
observed that, in the presence of filipin and natamycin the total aflatoxin production (ng/g)
also decreased at significant levels but not in the same manner which we treated with only
V. gazogenes cells (Figure 4.1C). On the other hand, the dry weight analysis at the end of
the incubation period revealed that the mycelial growth of A. flavus did not differ with 16
million V. gazogenes cells and the combination of V. gazogenes cells with filipin as
compared to the untreated control (Figure 4.1D). But we observed that the mycelial growth
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of A. flavus was significantly reduced while treated with natamycin along with 16 million
V. gazogenes cells.
4.3.2 Presence of A. flavus activates production of V. gazogenes lysing enzyme
Next, we investigated if V. gazogenes cells lysed in the presence of A. flavus
because we did not observe any evidence of intact bacterium within the hyphal cells with
transmission electron microscopy in our previous studies (Gummadidala, 2018). To
investigate the influence of A. flavus (CA14) in producing lysing enzymes by V. gazogenes
followed some steps which is shown diagrammatically in figure 4.2A. We conducted a
time-course measurement of the bacterial concentrations in the growth medium by
recording the OD600 readings to determine if, during the mycelial growth, the bacterial cells
were depleted or lysed in the growth media. When we added 50 µl of fresh 24 hr growing
V. gazogenes cells in 1 ml YES (Y) media, OD600 readings did not change significantly
after 6 h and 12 h time point. In the case of YES+ CA14 (YC) growth media, after adding
50 µl V. gazogenes cells, OD600 readings also did not change significantly at different time
points. But, when we added 50 µl of fresh 24 hr growing V. gazogenes cells in 1 ml YES
+ CA14 + Vg (YCV) growth media, OD600 dropped steadily and significantly from 0h to
12h time-point (Figure 4.2B), suggesting that presence of A. flavus with V. gazogenes in
YES media for 40 h activates the production of V. gazogenes lysing enzymes.
4.3.3 Prodigiosin is not the only aflatoxin inhibitor
To understand if the prodigiosin produce by V. gazogenes is the only aflatoxin
inhibitor, we treated A. flavus with a gram-negative bacterium, Serratia sp., which also
secrete a host of virulence factors including prodigiosin. It also helped us to observe the
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contribution of prodigiosin in aflatoxin inhibition. We also treated A. flavus with a gramnegative bacterium, Escherichia coli, and a gram-positive bacterium, Staphylococcus
aureus to understand if the aflatoxin inhibitory effect was limited to V. gazogenes. Besides
that, we treated A. flavus with two gram-negative, bioluminescent, marine bacterium Vibrio
harveyi and Vibrio fischeri or Aliivibrio fischeri which were nonviable or dead to test the
supposition that they were equally capable of decreasing aflatoxin levels in A. flavus
cultural media like dead V. gazogenes.
Non-viable bacterial biomass had proven to be better and safer bio adsorbent for
contaminants in the environment (Alshannaq et al., 2018; Farzaneh et al., 2016; Zeroual et
al., 2006) which are much preferred due to lack of nutrients and cultural conditions. As far
we know from our previous studies (Gummadidala, 2018) that, the unviable and viable V.
gazogenes cells equally inhibit aflatoxin biosynthesis, we used 16 million dead bacterial
cells to treat A. flavus and the fungus was harvested after 40 h. Dead bacteria cells were
used to reduce the pathogenic interaction between the A. flavus, Serratia sp., E. coli, S.
aureus, V. harveyi, and V. fischeri or A. fischeri. The growth of the A. flavus did not change
in the presence of Serratia sp., E. coli, S. aureus, V. harveyi, and A. fischeri and the
aflatoxin levels did not show any significant change except Serratia sp. (figure 4.3). As
Serratia sp. also produces prodigiosin like V. gazogenes, it has some aflatoxin inhibitory
effect on A. flavus, but it cannot inhibit aflatoxin production as the same level as V.
gazogenes did which was almost ~95%. This data points out that the prodigiosin produce
by V. gazogenes is not the only aflatoxin inhibitor and the aflatoxin inhibitory effect of V.
gazogenes is exclusive to itself.
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4.3.4 Intact V. gazogenes cell results in most efficient aflatoxin reduction
Since we observed prodigiosin is not the only functional component that is specific
to V. gazogenes, we proceeded to test whether intact and fractionated V. gazogenes cells
are impeded aflatoxin reduction in the same manner. We treated A. flavus with intact V.
gazogenes cells for 40 h. Besides that, we washed V. gazogenes cells with ethanol (EtOH)
precipitation method (Bajpai et al., 2016) and used that ethanol extract which we called
washate (red color) and precipitate which we called washed cell (white color) to treat A.
flavus. We used extracted washate and washed cells separately in two different A. flavus
growth flasks. We also used extracted washate and washed cells together in another A.
flavus growth flask. The scheme for this experiment is shown in Figure 4.3A. After 40 h
growth of treated A. flavus, the mycelial growth and aflatoxin synthesis were observed.
After 40 h the aflatoxin levels decreased with washate of V. gazogenes cells (Figure 4.3B)
but not like intact V. gazogenes cells. The aflatoxin levels also decreased with washed cells
and the combination of (washate + washed cells) of V. gazogenes cells but not like intact
V. gazogenes cells. The fungal mycelial mass did not change in different treatments. This
shows us that the intact V. gazogenes cells most effectively and efficiently decrease
aflatoxin production (>99%) rather than different fractionated parts of V. gazogenes cells.
4.4 DISCUSSION
Understanding how fungal uptake of V. gazogenes cellular materials leading to
aflatoxin downregulation is an area of agricultural and pharmaceutical promise and, in the
case of fungal pathogens such as A. flavus, a process to better understand pathways required
for aflatoxin synthesis and other virulence attributes. To date, research concerning the
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internalization of the bacteria via endocytosis like mechanism (Guerra-Tschuschke et al.,
1991). In this research, V. gazogenes allow us to study their secreted and synthesized
metabolic components and fractionated cell components which are assumed to be the
aflatoxin inhibitors. Based on the results of this study, we propose a theoretical model
(Figure 4.5) that summarizes our current understanding of how aflatoxin synthesis and
hyphal morphogenesis was disrupted in a V. gazogenes dependent manner. According to
this model, the internalization of cellular components of V. gazogenes in hyphae results in
the intervention of endosomal functions associated with hyphal morphogenesis and
aflatoxin biosynthesis.
The result of our current study showed that, in the presence of endocytosis
inhibitors (filipin and natamycin), A. flavus cannot uptake V. gazogenes in the same manner
while they are absent. Researchers showed that, ﬁlipin disrupts the conidial plasma
membrane of the ﬁlamentous fungus Penicillium discolor, whereas natamycin interferes
with endocytosis in a dose and time-dependent manner (van Leeuwen et al., 2009). The
findings reported in our study indicate that endocytosis inhibitors exposure induced
decreased aflatoxin inhibition especially in the case of natamycin. Also, results showed
that that the mycelial growth of A. flavus was significantly reduced while treated with
natamycin along with 16 million V. gazogenes cells. Considering the existing data, we
hypothesize that filipin and natamycin, two endocytosis inhibitors might be interfering with
endocytosis which reduces the endosomal uptake of V. gazogenes cells by A. flavus.
A research study showed bacterial active invasion into living fungal cells which
involves the secretion of chitinolytic enzymes by using rice seedling blight fungus
Rhizopus microsporus and its endosymbiont Burkholderia rhizoxinica, where they form an
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unusual, highly specific alliance to produce the highly potent antimitotic phytotoxin
rhizoxin (Moebius et al., 2014). To investigate the bacterial secretome, proteins include
secreted enzymes which usually help to invade into A. flavus cells, we experimented. We
did not find any intact V. gazogenes cells inside the fungal hyphae in our previous studies,
which driven us to examine how the uptaken of V. gazogenes cells happened. We assume
that, V. gazogenes cells might be lysed in bacteria-fungal growth media or V. gazogenes
cells might secrete lysing enzymes as secretome in bacterial-fungal growing media. The
OD600 reading showed a steady and significant drop from 0h to 12h time-point while we
use the media where we grew A. flavus and V. gazogenes together. This leads us to conclude
that V. gazogenes cells secrete lysis enzymes as secretomes in the presence of 24 h growth
media where A. flavus and V. gazogenes grow together.
It has been shown in our ELISA data that, Serratia sp. partially down-regulated
aflatoxin production but not as V. gazogenes did. Previous studies revealed that, other
fungal secondary metabolites trigger synthesis of metabolite fractions in V. gazogenes that
demonstrate different HPLC traces compared to prodigiosin which has antimalarial,
antifungal, immunosuppressant, and antibiotic properties (Hu et al., 2016; Williamson et
al., 2007). Our previous researcher also showed that after treating A. flavus cultures
(colorless or white) in YES liquid medium with live V. gazogenes (red color because of
prodigiosin synthesis) for 72 h, optical density decreased over time and the fungal mycelia
turned reddish pink (as attributed to the red pigment in the bacterial cells) and over a time
period of 42 h the bacteria were completely depleted from the YES media and the media
turned back to its original yellow (Gummadidala et al., 2016). In another study showed
that, Serratia marcescens produce red pigment as secondary metabolites named
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prodigiosin (de Assis Alcoforado Costa et al., 2019) which production can alter by using
differential and selective media (Darshan and Manonmani, 2016). Researchers assume in
their study report from there data that, mycotoxin triggered synthesis of mycotoxin
inhibitors is a phenomenon that is conserved in the Vibrio sp (Alihosseini et al., 2010;
Rameshkumar and Nair, 2009). We can hypothesize from our data that, prodigiosin might
be a functional component which can downregulate aflatoxin production but it is not the
only aflatoxin inhibitor and V. gazogenes might be synthesized some unique components
such as metabolite consortium or aflatoxin responsive metabolites (ARMs) or secretomes
which enable V. gazogenes to show the aflatoxin inhibitory effect specific to itself.
Moreover, our research data also revealed that other non-viable gram-negative and grampositive bacteria and some other Vibrio sp. have no aflatoxin inhibitory effect and mycelial
growth effect on A. flavus which support our hypothesis again.
The present study reports the efficiency of intact V. gazogenes cells on aflatoxin
reduction of A. flavus. In the bacterial-fungal biofilms, one form of association is the
internalization of bacteria by fungi altering the fungal physiology (Frey-Klett et al., 2011).
As far we know bacteria produce biofilm by which they can share nutrients and it acts as a
shelter from harmful factors in the environment, such toxic materials and a host body's
immune system, and exopolysaccharide (EPS) loci involved in biofilm formation have
been identified from numerous Vibrio sp. (Yildiz and Visick, 2009). V. gazogenes cells
produce significant biofilm outside the fungal cells when they grow together
(Gummadidala, 2018). In our research, we targeted the intact cell of V. gazogenes for
ethanol (EtOH) extraction which allows us to collect different metabolite fractions combine
with exopolysaccharides (EPS) for further treatments. The findings reported in this study
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indicate that different fractions of V. gazogenes cells ( washate – red color, washed cells –
white color and the combination of washate + washed cells) had separate aflatoxin
inhibitory effects but nobody can down-regulate aflatoxin production as intact V.
gazogenes cells.
In conclusion, our findings establish the foundation for a long-term study that will
investigate the molecular, cellular, and biochemical mechanisms underlying the aflatoxin
inhibitory effects of lysed and intact V. gazogenes cells, their secretomes and their secreted
exopolysaccharide combined with metabolite fractions on A. flavus. Current studies in our
laboratory reveal that fungal secondary metabolites trigger the synthesis of metabolic
components like lysis enzymes in V. gazogenes that need to be brought under further
investigation. Our future studies will shed light on revealing the individual components of
V. gazogenes producing secretomes when in contact with A. flavus. Further testing and
mechanistic understanding of ethanol consortium of V. gazogenes which related to the
formation of biofilm should be continued. To fully understand the impact of intact V.
gazogenes on aflatoxin down-regulation, the relative role of their individual fractionated
components needs to be observed.
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Figure 4.1: Influence of V. gazogenes (denoted as Vg in the figure) along with endocytosis
inhibitors on aflatoxin production and growth of A. flavus (CA14). (A). Mycelial growth
and color of mycelia in case of different treatments (Control- CA14 only, Ca14 with Vg,
CA14 with Vg and filipin, and CA14 with Vg and natamycin) at 40 h time point. (B) Color
intensity index of CA14 mycelial pellet in the presence of V. gazogenes endocytosis
inhibitors (filipin and natamycin) based on clinical score. Error bars represent SEM, from
triplicate experiments. Statistical significance of two-tailed p-values determined using an
unpaired t-test for n =16. (**, p<0.001). Star indicates significance.
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Figure 4.1(Continued): Influence of V. gazogenes and endocytosis inhibitors (filipin and
natamycin) uptake on aflatoxin production and growth of A. flavus (CA14). (C) Total
aflatoxin production (ng/g) per gram of mycelia at 40 hr time point, in the presence of V.
gazogenes and endocytosis inhibitors (filipin and natamycin). (D) The percentage of A.
flavus (CA14) mycelial dry weight in the presence of V. gazogenes and endocytosis
inhibitors (filipin and natamycin) at 40 hr time point. Error bars represent SEM, from
triplicate experiments. Statistical significance of two-tailed p-values determined using an
unpaired t-test for n =16. (**, p<0.001). Star indicates significance.
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Figure 4.2: Influence of A. flavus in producing lysing enzymes by V. gazogenes. (A).
Systematic diagram of treatment procedure of V. gazogenes cells by different media (with
and without A. flavus (B) Lysis of bacterial cells in different growth medium post spore
inoculation. Bacterial density in the growth medium as quantified by measuring the optical
density of the growth medium at 600nm (OD600). Error bars represent SEM, from triplicate
experiments. Statistical significance of two-tailed p-values determined using an unpaired
t-test for n =16. (**, p<0.001). Star indicates significance.

75

Figure 4.3: Influence of different bacteria along with V. gazogenes (non-viable) on
aflatoxin production and growth of A. flavus. Total aflatoxin production (ng/g) per gram of
mycelia at 40 hr time point was measured through ELISA. Error bars represent SEM, from
triplicate experiments. Statistical significance of two-tailed p-values determined using an
unpaired t-test for n =16. (**, p<0.001). Star indicates significance.
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Figure 4.4: Influence of intact and different fractionated parts of Vibrio gazogenes cells on
aflatoxin reduction of A. flavus. (A). Systematic diagram of treatment procedure of intact
V. gazogenes cells by ethanol (EtOH) precipitation method to treat A. flavus
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Figure 4.4 (Continued): Influence of intact and different fractionated parts of Vibrio
gazogenes cells on aflatoxin reduction of A. flavus. (B) Relative aflatoxin production (ng/g)
per gram of mycelia at 40 hr time point, in the presence of intact and different fractionated
parts of Vibrio gazogenes cells. (C) The dry weight of mycelia was plotted on the y-axis
and bars represent the measurements in grams. Statistical significance of two-tailed pvalues were determined using an unpaired t-test for n=3. Error bars represent SEM. (**,
p<0.001). Star represents the difference as compared to the control was statistically
significant.
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Figure 4.5: Theoretical model of disruption effects of V. gazogenes on aflatoxin synthesis
and hyphal morphogenesis. According to this model, the internalization of cellular
components of V. gazogenes in hyphae results in the intervention of endosomal functions
associated with hyphal morphogenesis and aflatoxin biosynthesis
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CHAPTER 5
CONCLUSIONS, FUTURE DIRECTIONS AND SIGNIFICANCE TO
PUBLIC HEALTH
5.1 SUMMARY OF CONCLUSIONS
In summary, Vibrio gazogenes cells have a significant impact on aflatoxin
reduction in A. flavus when interactions occur between them. Their cellular components
and metabolites almost completely inhibited aflatoxin production upon endosomal uptake.
The inhibition occurred at the levels of aflatoxin gene expression. Light, electron and
confocal microscopy collectively suggested that V. gazogenes dependent aflatoxin
inhibition was associated with internalization of bacterial cell materials but not intact
bacteria, in endosome-like compartments. We have investigated the effects of different
endocytosis inhibitors on endosomal uptake of V. gazogenes cells by A. flavus. The result
showed that A. flavus cannot uptake the same amount of V. gazogenes which also affect
the aflatoxin inhibition. In another study, we observed that presence of V. gazogenes in A.
flavus growth medium leads to a production of bacteriolytic components (to be
characterized in our future studies) that appeared to lyse the V. gazogenes cells; we
hypothesize based on these observations, that this lysate through endosomal uptake
inhibited hyphal morphogenesis, leading to reduced hyphal elongation, hyphal fusion, and
sclerotial formation. We have developed a novel assay for hyphal fusion and tested the
fusion process in the absence and presence of V. gazogenes. We also show that, V.
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gazogenes uptake results in an almost complete (>98%) block of hyphal fusion and an ~3fold decrease of polar growth, processes that depend on endosomal functions, and
transport. The inhibition of sexual structures (sclerotia) was correlated with higher asexual
spore formation. However, those spores generated colonies were ~2-fold less aflatoxigenic
than the earlier generation. Treating A. flavus with non-viable other gram-positive or gramnegative or prodigiosin producing bacterium did not have the same aflatoxin inhibitory
effect suggesting that V. gazogenes dependent aflatoxin inhibition was specific to V.
gazogenes and prodigiosin is not the only aflatoxin inhibitor. An intriguing finding in this
study was that only intact V. gazogenes cells when added to the growth medium resulted
in the most effective decrease aflatoxin production (>99%) rather than different
fractionated parts of V. gazogenes cells, suggesting that interactions between intact V.
gazogenes and the fungus is needed for the best results. In conclusion, our study has opened
a new research direction that leads to the development of a novel “green aflatoxin inhibitor”
and enables us to understand the bacteria-fungal interactions related to the prevention of
fungal infections and toxin contamination in the environment.
5.2 FUTURE DIRECTIONS
Our focus will be solely on the molecular and cellular mechanisms coordinating
secondary metabolic pathways and hyphal development in our follow-up experiment. In
the future, identifying the genes, proteins, and biochemical mechanisms associated with A.
flavus response to V. gazogenes cells need to be done. Mining fungal secretomes are
important for a range of applications, including identification of novel enzymes,
understanding fungal interactions with the environment, investigating pathogenic
mechanisms, epitope mapping, and identification of new vaccine candidates. Thus, we plan
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to characterize the secreted metabolic components and secretomes of A. flavus in the
presence and absence of V. gazogenes cells. To uncover the precise roles of the individual
fractionated components of V. gazogenes on aflatoxin inhibition, we also plan a further
investigation. Overall, our future studies are aimed at understanding the complex
mechanisms underlying V. gazogenes and A. flavus interactions that will be leveraged to
improve plant and human health.
5.3 BROADER SIGNIFICANCE TO PUBLIC HEALTH
The COVID-19 pandemic, also known as the coronavirus pandemic, is an ongoing
pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2).
More than 7.18 million cases of COVID-19 have been reported in more than 188 countries,
resulting in more than 408,000 deaths and it is still going on (WHO, 2020). Dealing with
the unforeseen challenges caused by the COVID-19 pandemic has taken a significant toll
on people across the world. Some reports suggest that patients recovering from COVID19 infections have an increased likelihood of developing invasive Aspergillosis and other
Aspergillus infections when exposed to Aspergillus spores or hyphae (Marion et al., 2020;
Verweij et al. 2020; Prattes et al., 2020). Conversely, aflatoxin and other mycotoxin
exposures that are appearing to increase in our foods with the changing climate, are
consistently threatening our immune system, which in turn can make us vulnerable to
COVID-19 and other microbial infections and other health disorders.
Besides that, one-fourth of the total crops produced in the world is wasted every
year due to fungal spoilage. With the ongoing pandemic that has severely impaired the
food supply chains worldwide, such wastages have increased significantly, and it predicted
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that this spoilage would increase with the impending climate change. With the associated
energy and water losses, this enormous food wastage is a critical emerging challenge to the
Food/Water/Energy (FWE) nexus because the global population is expected to reach ~9.6
billion by 2050 and as a consequence, the global food demand will see a 70%-100%
increase (FAO, 2018). My thesis directly addresses these ongoing public health challenges.
The knowledge from this research can be used in novel agricultural and
pharmaceutical practices to protect and improve the health of plants, humans, and their
communities in the future. It will lead to the development of “green antifungals” that can
prevent mold infestations in crops and improve the overall environmental health.
Simultaneously the research has the ability to generate a biopharmaceutical drug from our
novel tool to reduce the morbidity and mortality rate in immunocompromised patients due
to invasive aspergillosis disease. In summary, it will help to mitigate the toxic molds and
mycotoxins that threaten food safety and human health, and thereby improve public health.
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